DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	LTA; TNF; FCER2; PTPRC;	GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin	4	5	80	0.00010153949035951	0.00197239302323151	0.378843838531349	0.399253276093611	0.299744575541287	0.378843838531349	0.0174640536330801
down	ITGB2; CD2; PTPRC; CD1D; ITGAX; ITGB7; LILRB2;	GO:0034113~heterotypic cell-cell adhesion	7	29	24.1379310344828	0.00010183005689623	0.00197239302323151	0.379826112222956	0.400395783715996	0.300278547168768	0.379826112222956	0.0174640536330801
down	HLA-E; HLA-G; HLA-F; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	5	12	41.6666666666667	0.00012775570203005	0.0024267411612665	0.476273257168035	0.502335420382166	0.343790594162871	0.476017745763975	0.0214869639543371
down	HLA-G; HLA-H; FCGRT; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	5	12	41.6666666666667	0.00012775570203005	0.0024267411612665	0.476273257168035	0.502335420382166	0.343790594162871	0.476017745763975	0.0214869639543371
down	LYN; HLA-G; PDCD1; FCRLB; INPP5D;	GO:0050777~negative regulation of immune response	5	12	41.6666666666667	0.00012775570203005	0.0024267411612665	0.476273257168035	0.502335420382166	0.343790594162871	0.476017745763975	0.0214869639543371
down	LYN; MEF2C; PKN1; TNFSF13B; PPP2R3C; GAPT;	GO:0001782~B cell homeostasis	6	21	28.5714285714286	0.00014714714209307	0.00272916303165078	0.547534515728327	0.578582562709966	0.371184403541265	0.547534515728327	0.0241646816819908
down	TLR4; CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.00016507482321537	0.00301894979015276	0.614078342361184	0.649074204882843	0.395504469913692	0.613748192714753	0.0267305250169786
down	LYN; FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	4	6	66.6666666666667	0.00016507482321537	0.00301894979015276	0.614078342361184	0.649074204882843	0.395504469913692	0.613748192714753	0.0267305250169786
down	FCER2; PRF1; SYK; CLEC7A;	GO:0051712~positive regulation of killing of cells of other organism	4	6	66.6666666666667	0.00016507482321537	0.00301894979015276	0.614078342361184	0.649074204882843	0.395504469913692	0.613748192714753	0.0267305250169786
down	APOBEC3G; APOBEC3F; AICDA; APOBEC3H; APOBEC3D;	GO:0016554~cytidine to uridine editing	5	13	38.4615384615385	0.00017238553307286	0.00313805516686337	0.640757026431823	0.677819916042488	0.404244075055858	0.640757026431823	0.0277851133583298
up	CCL24; CCL21; CXCL11; NRP1; SIGLEC6; CXCL13; FADS1; C1QA; CXCL10; PDGFA; INHA; PGR; GJB1; INHBA; CGB7; PTHLH; BMP2; BMP3; EDN3; ADCYAP1; NTF3; EFNA1; GJA4; PGF; CCL18; CXCL6; TNFAIP6; EFNB1; CXCL9; FAT1; EFNB3; FGF14; TBX5; CCL13; IL26; STAB1; TRHDE; CCL26; DRD2; DRD1; ADRA1D; ADRA2C; ADRA2A;	GO:0007267~cell-cell signaling	43	230	18.695652173913	0.00017743307867779	0.172420594205144	0.689150077584541	0.689682376820574	0.689150077584541	0.689150077584541	1
down	BLOC1S3; DTNBP1; AP1M1; BLOC1S4; RAB29; RAB32;	GO:0032438~melanosome organization	6	22	27.2727272727273	0.00018238784857904	0.00325976827551278	0.677388469622578	0.717149020612811	0.416247066574554	0.677206081773999	0.028862791200558
down	TNFSF14; PTPRC; CCND3; PSMB10; PIK3CG; P2RX7;	GO:0042098~T cell proliferation	6	22	27.2727272727273	0.00018238784857904	0.00325976827551278	0.677388469622578	0.717149020612811	0.416247066574554	0.677206081773999	0.028862791200558
down	DHRS12; NCF1B; NCF1C; CYB561D2; CYBB; MPO; LDHB; IFI30; CYBA; MTHFD2; NCF2; IMPDH1; TBXAS1; GMPR; SNCA; BLVRA; CYP27A1; SELENBP1; KCNAB2; NCF4; SURF1; ASPHD2; DHRS13; PYROXD2; FADS6; CYB561A3; SDR9C7; FAR2; HIGD2A; RSAD1; MSRB1; GSTK1; DHRS7; STEAP4;	GO:0055114~oxidation-reduction process	34	526	6.4638783269962	0.00018322774061585	0.00325996143032371	0.680141373166052	0.72045147610154	0.417261860278217	0.680141373166052	0.0288645014408285
down	TNFSF12; TNF; IL6R; TNFRSF1B; CD27; CD70; FASLG; P2RX7;	GO:0097191~extrinsic apoptotic signaling pathway	8	44	18.1818181818182	0.000185135902657	0.00327907373534844	0.687039334760155	0.727954369247354	0.419527884156704	0.687039334760155	0.0290337264969265
down	MPO; CHI3L1; BTG2; PTK2B; ANKRD23; P2RX7; TXNIP; RETN; JUND;	GO:0009612~response to mechanical stimulus	9	57	15.7894736842105	0.00019257046667897	0.0033954577353441	0.714436431379002	0.757187074981735	0.428469288360722	0.714436431379002	0.0300642190985615
down	APBB1; EOMES; TNF; ELANE; FBP1; ZGLP1; UBB; AR; IRF2; HCLS1; TRIM27; GATA1; CD36; CEBPB; PTPN2; SPI1; GATA3; CCND3; TCF7; SNCA; FASLG; UBE2D1; BTG2; IRF8; HHEX; ARID5A; ZBTB16; MEF2C; GPS2; RUNX3; DRAP1; ZNF174; SNAI3; GFI1B; CIR1; NKAP; ZBTB2; SEMA4D; IRF7; TRIB3; ASCL2; TXNIP; LYAR; TBX21; CELA1; KLF2; JUND; ID2;	GO:0000122~negative regulation of transcription by RNA polymerase II	48	847	5.66706021251476	0.00020242276388948	0.00355324244470296	0.750786031266108	0.795926307613463	0.439054974876298	0.750786031266108	0.0314612837779977
down	RASSF2; NLRP12; TMSB4X; ADGRG3; ADIPOR1; NLRP3;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	6	23	26.0869565217391	0.00022396596742213	0.00389661143320281	0.830241841233855	0.880634183903835	0.461369892889598	0.830241841233855	0.0345015573748254
down	HP; SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.00025303719955005	0.004383005588682	0.937755861532503	0.994942268630815	0.486590534734755	0.937755861532503	0.0388082110275484
down	CASP1; CLEC7A; PYCARD; MNDA; PYHIN1;	GO:0032731~positive regulation of interleukin-1 beta production	5	15	33.3333333333333	0.00029626138884086	0.00502111974535472	1	1	0.519672924907653	0.999436947074871	0.0444582309398587
down	LYN; CYBA; PTPN6; CORO1A; PTK2B;	GO:0051279~regulation of release of sequestered calcium ion into cytosol	5	15	33.3333333333333	0.00029626138884086	0.00502111974535472	1	1	0.519672924907653	0.999436947074871	0.0444582309398587
down	CCL5; SPN; AIF1; DOCK8; PYCARD;	GO:2000406~positive regulation of T cell migration	5	15	33.3333333333333	0.00029626138884086	0.00502111974535472	1	1	0.519672924907653	0.999436947074871	0.0444582309398587
down	CCDC88B; TNF; SLC11A1; NFAM1; TMIGD2; HILPDA;	GO:0001819~positive regulation of cytokine production	6	25	24	0.00032928167606005	0.00550951297986442	1	1	0.539674811545434	0.999436947074871	0.0487825849306961
down	CCL5; CD1D; FPR2; ADAM8; GBP5; TLR8;	GO:0045089~positive regulation of innate immune response	6	25	24	0.00032928167606005	0.00550951297986442	1	1	0.539674811545434	0.999436947074871	0.0487825849306961
down	TNFSF12; PTPRC; BID; DEDD2; RBCK1; PYCARD;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	6	25	24	0.00032928167606005	0.00550951297986442	1	1	0.539674811545434	0.999436947074871	0.0487825849306961
down	MS4A1; ORAI1; ORAI3; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	CD160; HLA-E; HLA-G; HLA-F;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	P2RX1; P2RX5; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	TLR4; SYK; LTB; CLEC7A;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	CCL5; CD27; DOCK8; SLC46A2;	GO:0070233~negative regulation of T cell apoptotic process	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	MYO1G; ITGB7; ZAP70; CCR6;	GO:0072678~T cell migration	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	LGALS9; CD160; CD2; CD244;	GO:1902715~positive regulation of interferon-gamma secretion	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	ELANE; PTAFR; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.00037025109910615	0.00599105893697697	1	1	0.562411419542251	0.999436947074871	0.0530463114409573
down	LRMP; STX8; DYSF; STX10; STX11; SYT11; STX3;	GO:0006906~vesicle fusion	7	38	18.4210526315789	0.00043445751400261	0.00697259977574813	1	1	0.596944624239596	0.999436947074871	0.0617371157834274
down	OAZ2; PSMB8; PSMB9; PSMB10; PSMB3; OAZ1; PSME1; PSMF1;	GO:0006521~regulation of cellular amino acid metabolic process	8	51	15.6862745098039	0.00045073228081926	0.00720438751293233	1	1	0.604431988578636	0.999436947074871	0.063789421498362
down	CD3E; CD36; CCR7; PTK2B; SKAP1; NINJ1;	GO:0001954~positive regulation of cell-matrix adhesion	6	27	22.2222222222222	0.00046986993057562	0.0074798727409853	1	1	0.613180259401195	0.999436947074871	0.0662286355602511
down	APOBEC3H; APOBEC3F; APOBEC3D; APOBEC3G; AICDA;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	5	17	29.4117647058824	0.00047796340268546	0.00754759879260744	1	1	0.617004570904234	0.999436947074871	0.0668282987024113
down	ITGB2; CD36; CES1; FCER1G; SYK;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	5	17	29.4117647058824	0.00047796340268546	0.00754759879260744	1	1	0.617004570904234	0.999436947074871	0.0668282987024113
down	TPP1; TFEB; CLN3; LRRK2; CLVS1; HPS1; NAGPA;	GO:0007040~lysosome organization	7	39	17.9487179487179	0.0004988608014731	0.00781482339200091	1	1	0.625571445047267	0.999436947074871	0.0691943711235355
down	MT1F; CYBB; NCF1; MMP9; MT1H; DAXX; MT1L;	GO:0071276~cellular response to cadmium ion	7	39	17.9487179487179	0.0004988608014731	0.00781482339200091	1	1	0.625571445047267	0.999436947074871	0.0691943711235355
down	HLA-H; HLA-E; HLA-G; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	NCR3; CRTAM; PECAM1; CLEC7A;	GO:0008037~cell recognition	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	LY86; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	IL2RG; STAT5A; STAT5B; JAK3;	GO:0038113~interleukin-9-mediated signaling pathway	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	CRTAM; CD4; CCL5; SIT1;	GO:0050863~regulation of T cell activation	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	ISG15; TRIM27; GATA3; LILRB1;	GO:0072643~interferon-gamma secretion	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	TLR4; CD36; GBP5; TLR6;	GO:1900227~positive regulation of NLRP3 inflammasome complex assembly	4	9	44.4444444444444	0.0005217107993265	0.00795103435252639	1	1	0.632958278195607	0.999436947074871	0.0704004165171321
down	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	FCER1G; SYK; P2RX1;	GO:0002554~serotonin secretion by platelet	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	PIK3CD; MPO; PIK3CG;	GO:0002679~respiratory burst involved in defense response	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00055107102708518	0.00814590706202607	1	1	0.642383789259689	0.999436947074871	0.0721258674846833
down	LCK; CSF1R; CCR2; ZFP36L2; ZBTB16; GLRX5; AHSP; RUNX3;	GO:0030097~hemopoiesis	8	53	15.0943396226415	0.00056686690322915	0.00834801746628107	1	1	0.647362003487698	0.999436947074871	0.0739154027842606
down	EOMES; CSF1R; ID2; LRRK2; CRTAC1;	GO:0021772~olfactory bulb development	5	18	27.7777777777778	0.00059523310032316	0.00857310091747506	1	1	0.656428862935104	0.999436947074871	0.0759083470997553
down	IRF8; ZBTB16; RASGRP4; KAT8; SNRK;	GO:0030099~myeloid cell differentiation	5	18	27.7777777777778	0.00059523310032316	0.00857310091747506	1	1	0.656428862935104	0.999436947074871	0.0759083470997553
down	ASGR1; LYN; PTPRC; AIF1; GSDMD;	GO:0031668~cellular response to extracellular stimulus	5	18	27.7777777777778	0.00059523310032316	0.00857310091747506	1	1	0.656428862935104	0.999436947074871	0.0759083470997553
down	SELL; P2RX1; P2RX5; P2RX4; P2RX7;	GO:0033198~response to ATP	5	18	27.7777777777778	0.00059523310032316	0.00857310091747506	1	1	0.656428862935104	0.999436947074871	0.0759083470997553
down	RAB29; UBB; CCL5; EPHB1; LRRK2;	GO:1901214~regulation of neuron death	5	18	27.7777777777778	0.00059523310032316	0.00857310091747506	1	1	0.656428862935104	0.999436947074871	0.0759083470997553
up	PRSS38; PRSS37; TRABD2B; ADAMDEC1; KLK10; TLL1; PRSS23; ECEL1; HPR; CFB; CFI; CTSG; MMP7; MMP10; BMP1; CTSE; CPA3; KEL; CASP14; PRSS3; GGT5; MMP12; MMP14; MMP16; RHBDL3; HTRA3; TMPRSS15; WFDC2; HABP2; PRSS53; MMEL1; CPZ; PM20D1; CASP12; OVCH1; OVCH2; ADAMTSL2; DPP10; ADGB; ADAMTS19; HTRA1; GGH; ADAM33; TINAGL1; MMP28; MMP27; ADAMTS10; ADAMTS1; FBXO2; FBXL2; KLK13; TLL2; CAPN8; PGA5; CAPN9; F12; TPSAB1; CPA6; CPO; TPSB2; CAPN6; PLAU; PGA3; TRHDE; PGC; TPSD1; TPSG1;	GO:0006508~proteolysis	67	436	15.3669724770642	0.00061097817162703	0.474974430622853	1	1	0.999999999669243	0.999999999669243	1
down	TLR4; APBB1; EOMES; TNF; PF4; CD3D; WNT1; ADRB2; UBB; AR; GTF2F2; IRF2; HCLS1; GATA1; JUND; CEBPB; SPI1; TFEB; USF1; GATA3; LMO2; TNFSF8; WAS; SLC11A1; ARRB1; CEBPD; STAT5B; NRL; FLI1; SPIB; IRF8; HHEX; MEF2C; GPS2; PIN1; IRF5; CAMK1; RPS6KA1; BATF; PCGF5; NFE4; SKAP1; METTL23; CRLF3; LILRB1; IRF7; EAF2; NLRP3; IER2; RGCC; BEX1; CELA1; KLF2; ASCL2; STAT5A; KAT8; SS18L2; TBX21;	GO:0045944~positive regulation of transcription by RNA polymerase II	58	1138	5.09666080843585	0.00061430962830011	0.0088155673667009	1	1	0.662370795090084	0.999436947074871	0.0780552047613004
down	GATA1; GATA3; LMO2; PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1;	GO:1902036~regulation of hematopoietic stem cell differentiation	9	68	13.2352941176471	0.00061987678756159	0.00886311101342609	1	1	0.664175017535818	0.999436947074871	0.0784761679195256
down	HCLS1; WAS; AIF1; CORO7; PREX1; MSRB1;	GO:0030041~actin filament polymerization	6	29	20.6896551724138	0.00065325331043886	0.0092395396282216	1	1	0.674810669683344	0.999436947074871	0.0818091595902445
down	LGALS9; TLR4; PGLYRP1; HLA-DRB1; GATA3; LILRB1;	GO:0032689~negative regulation of interferon-gamma production	6	29	20.6896551724138	0.00065325331043886	0.0092395396282216	1	1	0.674810669683344	0.999436947074871	0.0818091595902445
down	TNF; CSF1R; LYN; IL6R; CCL5; HCLS1; PECAM1; IL23R; IL27RA;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	9	69	13.0434782608696	0.00068173138856153	0.00960776996352672	1	1	0.68377658272722	0.999436947074871	0.0850695616750987
down	RAC2; TNFRSF1B; TNFSF8; IL27;	GO:0042129~regulation of T cell proliferation	4	10	40	0.00071252885465278	0.00997033258539055	1	1	0.693470976517689	0.999436947074871	0.0882797804291714
down	TLR4; CD36; MYD88; TLR6;	GO:0140052~cellular response to oxidised low-density lipoprotein particle stimulus	4	10	40	0.00071252885465278	0.00997033258539055	1	1	0.693470976517689	0.999436947074871	0.0882797804291714
down	CD160; HLA-G; CD40LG; FASLG; RGCC;	GO:2000353~positive regulation of endothelial cell apoptotic process	5	19	26.3157894736842	0.00073280952370913	0.010217755486611	1	1	0.699833095142222	0.999436947074871	0.0904705237374637
down	PSMB8; PSMB9; PSMB10; PSMB3; PSME1; MIIP; PSMF1; GPR132;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	8	56	14.2857142857143	0.00078528870640792	0.0109107957370882	1	1	0.711988425359388	0.999436947074871	0.0966068728127547
down	NEURL1; CSF1R; LYN; AR; IFITM1; GATA1; TIMP2; PTPN2; CD33; GATA3; TNFRSF8; PTPN6; SSTR3; CDKN2D; CCL23; BTG1; CSNK2B; BTG2; ZBTB16; PTK2B; SFRP5; TESC; TSPAN32; RGCC; SIRPG; PIM2;	GO:0008285~negative regulation of cell population proliferation	26	396	6.56565656565657	0.00079893354146076	0.0110612911444498	1	1	0.715045519607386	0.999436947074871	0.0979393962169331
down	RGS14; GNG7; RGS2; GRK6; RGS6; RASGRP4; RGS18;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	7	43	16.2790697674419	0.00083625837684553	0.0115374313605496	1	1	0.723765792945562	0.999436947074871	0.10215525896482
down	TNF; ELANE; IL6R; CYBA; CCL5; PTAFR; AIF1; ID2;	GO:0048661~positive regulation of smooth muscle cell proliferation	8	57	14.0350877192982	0.00087150931811419	0.0118985230514757	1	1	0.732057384775527	0.999436947074871	0.105352453734076
down	S1PR4; C5AR1; PLCB2; RASGRP4; NMUR1; LPAR2;	GO:0007202~activation of phospholipase C activity	6	31	19.3548387096774	0.00088765864076623	0.0119812667512553	1	1	0.735782778501991	0.999436947074871	0.106085086831907
down	ISG15; GATA1; STAT5B; ID2; INPP5D; FAM210B;	GO:0045648~positive regulation of erythrocyte differentiation	6	31	19.3548387096774	0.00088765864076623	0.0119812667512553	1	1	0.735782778501991	0.999436947074871	0.106085086831907
down	TLR4; CD14; UBB; UBE2D1; LY96;	GO:0002756~MyD88-independent toll-like receptor signaling pathway	5	20	25	0.00089280548273595	0.0119812667512553	1	1	0.736822741488993	0.999436947074871	0.106085086831907
down	APOBEC3H; APOBEC3F; APOBEC3D; APOBEC3G; AICDA;	GO:0010529~negative regulation of transposition	5	20	25	0.00089280548273595	0.0119812667512553	1	1	0.736822741488993	0.999436947074871	0.106085086831907
down	APOBEC3F; AICDA; APOBEC3H; APOBEC3G; APOBEC3D;	GO:0080111~DNA demethylation	5	20	25	0.00089280548273595	0.0119812667512553	1	1	0.736822741488993	0.999436947074871	0.106085086831907
down	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	TNFRSF1B; CCR2; CLC;	GO:0002724~regulation of T cell cytokine production	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	CD14; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	FCER1G; CSF2RB; SYK;	GO:0038156~interleukin-3-mediated signaling pathway	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	IFI30; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	IL16; NLRP10; P2RX7;	GO:0050717~positive regulation of interleukin-1 alpha secretion	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	CD14; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.00094213942774323	0.0120229065219701	1	1	0.747818921109905	0.999436947074871	0.106453775617797
down	CRTAM; CTSH; PRF1; GZMM;	GO:0001913~T cell mediated cytotoxicity	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	PGLYRP1; HLA-DRB1; CD1D; NLRC4;	GO:0016045~detection of bacterium	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	CARD16; SIGIRR; LILRA2; CARD8;	GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	IFITM1; MX2; IFNAR2; IFITM2;	GO:0035455~response to interferon-alpha	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	CD4; HLA-DRB1; CD74; FES;	GO:0045657~positive regulation of monocyte differentiation	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	IL27RA; BANK1; SYT11; C5AR2;	GO:1900165~negative regulation of interleukin-6 secretion	4	11	36.3636363636364	0.0009478893748247	0.0120229065219701	1	1	0.748768221596171	0.999436947074871	0.106453775617797
down	TYROBP; TNF; CSF1R; FCER1G; OSCAR; SNX10;	GO:0030316~osteoclast differentiation	6	32	18.75	0.00102674480691833	0.0128982766159837	1	1	0.76117588832918	0.999436947074871	0.11420451803606
down	GZMA; CTSS; CPVL; CTSW; CTSH; CTSA;	GO:0051603~proteolysis involved in cellular protein catabolic process	6	32	18.75	0.00102674480691833	0.0128982766159837	1	1	0.76117588832918	0.999436947074871	0.11420451803606
down	GNAI2; GNAZ; FPR2; OPRL1; OXER1; MARCO; PTGDR2; PSAP;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	8	59	13.5593220338983	0.0010666828214857	0.0133573148219165	1	1	0.765939518849682	0.999436947074871	0.11826895537366
down	PRKCB; CCL5; CORO1A; CCR1; ATP2A3; NMUR1; CYSLTR1; CATSPER1; CACNA1E;	GO:0006816~calcium ion transport	9	74	12.1621621621622	0.00107113807667369	0.0133705235475586	1	1	0.766538410107094	0.999436947074871	0.118385908683838
down	TNF; GPM6A; IL10RA; PTPRO; SLITRK4;	GO:0050807~regulation of synapse organization	5	21	23.8095238095238	0.00107739764612758	0.0134060998246001	1	1	0.767143290277081	0.999436947074871	0.11870090980329
up	CCL21; NRP1; FGF10; RAMP3; SEMA7A; PDGFB; PDGFA; NTRK1; APP; SERPINF2; BMP2; DRD2; PLA2G2A; ALOX15; CD44; ADCYAP1; S100A7; CHRNA7; THPO; CASR; SYT14P1; FFAR4; NPNT; NODAL; CCL19; NOX4; IL26; TREM2; CCL11; HMGB1P1; CCL24; CCL14; CCL2; CCL13; CCL26; NTRK2; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	37	209	17.7033492822967	0.00114793051171458	0.637429414147796	1	1	0.999999999669243	0.999999999669243	1
down	FPR1; CXCR2; CX3CR1; NMUR1; C5AR1; C3AR1; C5AR2; FPR2;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	8	60	13.3333333333333	0.00117655806521211	0.0144781209341956	1	1	0.77843769213962	0.999436947074871	0.128192848749158
down	TNF; ELANE; PIK3CG; ADAM8; S100A12; LRRK2; EPGN; PIK3R5;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.00117655806521211	0.0144781209341956	1	1	0.77843769213962	0.999436947074871	0.128192848749158
down	GABARAP; TNF; FASLG; BID; DEDD2; DAXX;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	6	33	18.1818181818182	0.00118196256863601	0.0144781209341956	1	1	0.778923525104995	0.999436947074871	0.128192848749158
down	MYL4; TNNI3; GRK2; MAP2K3; KCNQ1; CXCR4; TNNI2;	GO:0060048~cardiac muscle contraction	7	46	15.2173913043478	0.00119095704279348	0.0145429909697639	1	1	0.780076863029732	0.999436947074871	0.128767224021734
down	PRF1; CORO1A; EPHB1; DOCK8;	GO:0001771~immunological synapse formation	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	PIK3CD; PTPRC; STAT5B; ID2;	GO:0001779~natural killer cell differentiation	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	CD4; P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	MEFV; JAK3; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	IL18RAP; CCL5; CXCR2; PREX1;	GO:0042119~neutrophil activation	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	JAK3; TIGIT; LAX1; TNFAIP8L2;	GO:0050868~negative regulation of T cell activation	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	TNF; CSF1R; AIF1; PYCARD;	GO:0090197~positive regulation of chemokine secretion	4	12	33.3333333333333	0.00123300577961483	0.0147361055484666	1	1	0.78419167583503	0.999436947074871	0.130477108066176
down	CD4; HLA-DRB1; CSF1R; MMP9; SPI1;	GO:0030225~macrophage differentiation	5	22	22.7272727272727	0.00128881821514315	0.0152639554877797	1	1	0.789519295833399	0.999436947074871	0.13515082143963
down	MMP9; FASLG; SHKBP1; DOK1; PDE6G;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	5	22	22.7272727272727	0.00128881821514315	0.0152639554877797	1	1	0.789519295833399	0.999436947074871	0.13515082143963
down	TNFSF12; PTPN6; HHEX; HLX; DUSP6; TMEM176B; SFRP5; MYO7B; CATSPERG; FCRLA; SLC22A16; CATSPER1; GTSF1; PBXIP1; TESC; EID2B; ODF3; HEMGN; RBM38; BEX1; TDRKH; NHSL2; LCK; LYN; FLI1; ID2; BLK; FGR; SPI1; FES; SPIB; SLA; HCK;	GO:0030154~cell differentiation	33	572	5.76923076923077	0.00140502191855174	0.0165405574363636	1	1	0.800595749249659	0.999436947074871	0.146454169522679
down	SYK; LILRA2; FCER1G;	GO:0002283~neutrophil activation involved in immune response	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	PIK3CG; PLIN5; SORL1;	GO:0010897~negative regulation of triglyceride catabolic process	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	CNR2; MILR1; CD300LF;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	SCIMP; PIK3AP1; UNC93B1;	GO:0034154~toll-like receptor 7 signaling pathway	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	PECAM1; CCR2; JAML;	GO:0035696~monocyte extravasation	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	LRRK2; TMEM175; CXorf21;	GO:0035751~regulation of lysosomal lumen pH	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	ALOX5; NLRP12; DOCK8;	GO:0036336~dendritic cell migration	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	CST3; CXCR4; BNIP3L;	GO:0043067~regulation of programmed cell death	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	LGALS9; PRTN3; CCR7;	GO:0097029~mature conventional dendritic cell differentiation	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	CST7; CARD16; CARD8;	GO:0097340~inhibition of cysteine-type endopeptidase activity	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	RAB32; HPS1; TRAPPC6A;	GO:1903232~melanosome assembly	3	5	60	0.00147272317637537	0.0167362645361501	1	1	0.807052300653702	0.999436947074871	0.148187008387342
down	FFAR2; DYSF; CD36; STAT5B; PLIN5;	GO:0019915~lipid storage	5	23	21.7391304347826	0.00152934655574022	0.0172303457225517	1	1	0.812198586195306	0.999436947074871	0.152561724905187
down	IL12RB1; STAT5B; IL23R; TMIGD2; PYCARD;	GO:0042104~positive regulation of activated T cell proliferation	5	23	21.7391304347826	0.00152934655574022	0.0172303457225517	1	1	0.812198586195306	0.999436947074871	0.152561724905187
down	TPP1; ADRB2; RAC2; PTK2B; SNX10;	GO:0045453~bone resorption	5	23	21.7391304347826	0.00152934655574022	0.0172303457225517	1	1	0.812198586195306	0.999436947074871	0.152561724905187
down	PGLYRP1; DEFA4; GNLY; DEFA3; LYZ; S100A12;	GO:0031640~killing of cells of other organism	6	35	17.1428571428571	0.00154562714288065	0.0173640169308763	1	1	0.813877237373786	0.999436947074871	0.15374528270725
down	LPXN; LYN; PIK3CG; TESC;	GO:0033628~regulation of cell adhesion mediated by integrin	4	13	30.7692307692308	0.0015730827265521	0.0174727719796691	1	1	0.81642993508054	0.999436947074871	0.154708226695905
down	DCK; GMPR; AMPD2; DGUOK;	GO:0043101~purine-containing compound salvage	4	13	30.7692307692308	0.0015730827265521	0.0174727719796691	1	1	0.81642993508054	0.999436947074871	0.154708226695905
down	RGS14; PLEK; CCL5; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	4	13	30.7692307692308	0.0015730827265521	0.0174727719796691	1	1	0.81642993508054	0.999436947074871	0.154708226695905
down	CTSH; GATA1; CTSS; LMO2;	GO:0097067~cellular response to thyroid hormone stimulus	4	13	30.7692307692308	0.0015730827265521	0.0174727719796691	1	1	0.81642993508054	0.999436947074871	0.154708226695905
down	TRIM21; ARRB1; NLRP12; TMSB4X; COMMD7; NLRP3; RBCK1; PYCARD; CARD8;	GO:0032088~negative regulation of NF-kappaB transcription factor activity	9	79	11.3924050632911	0.00162351484735324	0.0179821419149096	1	1	0.821373578913884	0.999436947074871	0.159218313561627
down	CYBB; CYBA; NCF1; VAV1; NCF2; PTK2B; NCF4; CYFIP2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	8	64	12.5	0.00170940802227204	0.0188803155718361	1	1	0.829261581703611	0.999436947074871	0.167170964342497
down	CCL5; CEBPB; CHI3L1; TANK; PYCARD; KLF2; XCL2; CCL4; CCL23;	GO:0071347~cellular response to interleukin-1	9	81	11.1111111111111	0.00189997196277436	0.0208678484849966	1	1	0.847387495397365	0.999436947074871	0.184769070290001
down	IL23R; SLAMF6; MYD88; LY9;	GO:0032740~positive regulation of interleukin-17 production	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	P2RY10; GPR171; PTAFR; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	PIK3CD; PIK3CG; MILR1; LAT2;	GO:0043303~mast cell degranulation	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	TNF; ALOX5; GPS2; LGALS12;	GO:0045598~regulation of fat cell differentiation	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	EIF4EBP3; BANK1; PAIP2; C8orf88;	GO:0045947~negative regulation of translational initiation	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	DYSF; PRTN3; SYT11; ATG3;	GO:0050765~negative regulation of phagocytosis	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	LYN; STAT5A; STAT5B; JAK3;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	ITGB2; ITGAM; C5AR1; MARCO;	GO:0097242~amyloid-beta clearance	4	14	28.5714285714286	0.00197328192468715	0.0211993019887155	1	1	0.854431073389537	0.999436947074871	0.187703841249765
down	HP; SERPINA1; ORM1; IL6R; CEBPB; SIGIRR;	GO:0006953~acute-phase response	6	37	16.2162162162162	0.00198862717188431	0.0213059456126678	1	1	0.85579555537352	0.999436947074871	0.188648090162833
down	BIN1; HCK; CCR7; GRB2; PTK2B; PYCARD; CDC42EP3;	GO:0030838~positive regulation of actin filament polymerization	7	51	13.7254901960784	0.00203272471879368	0.0216018205251263	1	1	0.859842556049725	0.999436947074871	0.191267839512479
down	SYK; IRF7; MYD88; POLR3GL; ZBP1; POLR3K; CD14;	GO:0032481~positive regulation of type I interferon production	7	51	13.7254901960784	0.00203272471879368	0.0216018205251263	1	1	0.859842556049725	0.999436947074871	0.191267839512479
down	PLEK; PTPRC; PTPN6; CEBPD; KCNAB2; ARL11; PLD4; CSF1R;	GO:0002244~hematopoietic progenitor cell differentiation	8	66	12.1212121212121	0.00203912812330986	0.0216114603257531	1	1	0.860512068036762	0.999436947074871	0.191353192681535
up	KRT34; KRT37; KRT75; IVL; KRT19; SPRR1B; SPRR2E; CASP14; SPRR1A; SPRR2B; SPRR2A; KRT20; KRT72; KRT31; SPINK9; LIPM; KRT40; CERS3; SPRR2F; LCE3D; SPRR2G; SPRR3; KLK13;	GO:0070268~cornification	23	113	20.353982300885	0.00204492853695404	0.751860413081793	1	1	0.999999999669243	0.999999999669243	1
down	TLR4; SASH3; CD40LG; FCER1G; TIGIT;	GO:0032733~positive regulation of interleukin-10 production	5	25	20	0.00210702978383048	0.0218161816356137	1	1	0.865997493427755	0.999436947074871	0.193165845582418
down	MT1F; MT1H; MT1L; HVCN1; P2RX4;	GO:0071294~cellular response to zinc ion	5	25	20	0.00210702978383048	0.0218161816356137	1	1	0.865997493427755	0.999436947074871	0.193165845582418
down	PTPRC; HLA-G; LILRB1;	GO:0001915~negative regulation of T cell mediated cytotoxicity	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	AOC2; SULT1A1; SULT1A2;	GO:0006584~catecholamine metabolic process	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	SRGN; GZMH; GZMB;	GO:0008626~granzyme-mediated apoptotic signaling pathway	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	HCLS1; EVI2B; TESC;	GO:0030854~positive regulation of granulocyte differentiation	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	ISG15; HERC5; UBE2L6;	GO:0032020~ISG15-protein conjugation	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	C5AR1; IRF5; CARD9;	GO:0032494~response to peptidoglycan	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	CD3E; CCL5; SKAP1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	CORO1A; RAB27A; UNC13D;	GO:0043320~natural killer cell degranulation	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	APOBEC3H; APOBEC3F; APOBEC3G;	GO:0048525~negative regulation of viral process	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	IFIT1; TSPAN32; HERC5;	GO:0050688~regulation of defense response to virus	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	CD19; SH2B2; LAX1;	GO:0050851~antigen receptor-mediated signaling pathway	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	BATF; SLAMF6; LY9;	GO:0072540~T-helper 17 cell lineage commitment	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	SIGLEC16; CYBA; NLRP10;	GO:1900426~positive regulation of defense response to bacterium	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	IL12RB1; IL23R; NLRP10;	GO:2000318~positive regulation of T-helper 17 type immune response	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	LGALS9; GATA3; IL17RA;	GO:2000667~positive regulation of interleukin-13 secretion	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
down	HLA-G; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00215831501939312	0.0218161816356137	1	1	0.869769717252715	0.999436947074871	0.193165845582418
up	COL6A5; ISLR; SUSD5; NUAK1; MPDZ; FN1; APP; ITGAV; LAMB1; THBS1; HAPLN1; CCL2; CEACAM1; CD44; ITGB4; ITGB6; CD9; CDH3; TNC; AZGP1; LAMA1; L1CAM; THBS2; COL15A1; MCAM; CCL11; CDH11; LGALS4; CLDN10; SRPX; TNFAIP6; EFNB1; COL4A3; COL7A1; COL16A1; DPT; LGALS3BP; MFGE8; SPOCK1; MMRN1; MSLN; TPBG; LAMC2; COL4A6; LY6D; MYBPC2; FAT1; HABP2; PTPRK; FLG2; HES5; AMTN; PTPRU; COL12A1; OMD; FERMT1; STAB1; NTM; LOXL2; SIGLEC6; PCDHB5; PCDHGB4; PCDHA4; ICAM5; PCDHGC4; TGFBI;	GO:0007155~cell adhesion	66	454	14.5374449339207	0.00226672985692167	0.751860413081793	1	1	0.999999999669243	0.999999999669243	1
up	UGT1A9; CYP2C18; UGT1A3; CYP27C1; CYP2S1; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	9	25	36	0.00232115383508658	0.751860413081793	1	1	0.999999999669243	0.999999999669243	1
down	SRGN; NLRP12; SYT11; RGCC;	GO:0050710~negative regulation of cytokine secretion	4	15	26.6666666666667	0.00243869156434662	0.0245870134128485	1	1	0.883497346773631	0.999436947074871	0.217699472600927
down	RGS14; LYN; PTPN6; RGS2; SORL1; CD300A;	GO:0043407~negative regulation of MAP kinase activity	6	39	15.3846153846154	0.0025213710933788	0.0252908957631771	1	1	0.887222990189466	0.999436947074871	0.223931820298739
down	OPRL1; C3AR1; GPR65; P2RY10; GPR20; GPR35;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	6	39	15.3846153846154	0.0025213710933788	0.0252908957631771	1	1	0.887222990189466	0.999436947074871	0.223931820298739
down	VAV1; RGS19; RUNDC3A; RGL4; SH2D3C; DOCK8; RASGRP4; RHEBL1; ARHGAP30;	GO:0007264~small GTPase mediated signal transduction	9	85	10.5882352941176	0.00256520747431777	0.025599989312227	1	1	0.88900559469465	0.999436947074871	0.22666861071255
up	PDLIM1; PKHD1; CD44; CRISP2; SOX9; ITGA8; FOXF1; FAT1; NLGN2; FBLIM1; NRCAM; ROPN1B; TENM2; CRNN; CTNNA3; ICAM5; ZAN; CDH11; LAMA3; CDH13; CELSR3; CDH12; CDH3; FAT4; COL16A1; CDH26; CDH19; LAMA5;	GO:0098609~cell-cell adhesion	28	152	18.4210526315789	0.00261452448741095	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PIK3CD; CD4; PTAFR; PIK3CG; BATF;	GO:0001816~cytokine production	5	27	18.5185185185185	0.002829310119707	0.0280930489663836	1	1	0.900181749896717	0.999436947074871	0.248742774937348
down	CD14; AIF1; BTG2; EEF1A2; P2RX7;	GO:0051602~response to electrical stimulus	5	27	18.5185185185185	0.002829310119707	0.0280930489663836	1	1	0.900181749896717	0.999436947074871	0.248742774937348
down	TNFSF14; CCL5; CCR2; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	4	16	25	0.00297429910819647	0.02868132962585	1	1	0.906665626197153	0.999436947074871	0.253951556791277
down	SRGN; GATA1; CCR1; PTK2B;	GO:0030502~negative regulation of bone mineralization	4	16	25	0.00297429910819647	0.02868132962585	1	1	0.906665626197153	0.999436947074871	0.253951556791277
down	PIK3AP1; MYD88; UNC93B1; TLR8;	GO:0034162~toll-like receptor 9 signaling pathway	4	16	25	0.00297429910819647	0.02868132962585	1	1	0.906665626197153	0.999436947074871	0.253951556791277
down	CYBB; CYBA; NCF1; NCF2;	GO:0042554~superoxide anion generation	4	16	25	0.00297429910819647	0.02868132962585	1	1	0.906665626197153	0.999436947074871	0.253951556791277
down	CARD16; NLRP3; NLRC4; CARD8;	GO:0050713~negative regulation of interleukin-1 beta secretion	4	16	25	0.00297429910819647	0.02868132962585	1	1	0.906665626197153	0.999436947074871	0.253951556791277
down	CD74; CCR7; SLC11A1;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	SKAP1; PYCARD; SASH3;	GO:0002821~positive regulation of adaptive immune response	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	HLA-DRB1; GPX1; NLRP6;	GO:0002862~negative regulation of inflammatory response to antigenic stimulus	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	CCL5; IL23R; IL6R;	GO:0010536~positive regulation of activation of Janus kinase activity	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	VNN1; VNN2; VNN3;	GO:0015939~pantothenate metabolic process	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	BPI; CD33; ARRB1;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	TLR4; CD14; LY96;	GO:0034128~negative regulation of MyD88-independent toll-like receptor signaling pathway	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	PTPRC; SYK; STAT5B;	GO:0045588~positive regulation of gamma-delta T cell differentiation	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	CXCR4; CSNK2B; CCM2;	GO:0061154~endothelial tube morphogenesis	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	RNF113A; CCL5; PADI2;	GO:0070100~negative regulation of chemokine-mediated signaling pathway	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	CCL5; PDCD1; PRELID1;	GO:0070234~positive regulation of T cell apoptotic process	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	LGALS9; CCR7; CCR6;	GO:2000510~positive regulation of dendritic cell chemotaxis	3	7	42.8571428571429	0.00301256081777113	0.02868132962585	1	1	0.908146224536027	0.999436947074871	0.253951556791277
down	SNN; MBP; LYN; CCL4; CCL5; CES1; SLC6A1; AQP10;	GO:0009636~response to toxic substance	8	71	11.2676056338028	0.00308386272097838	0.0291484332184783	1	1	0.91121276022603	0.999436947074871	0.258087407049204
down	ADAP1; TRAPPC6A; VAV1; FGD3; FGD2; PYCARD; ARHGAP9; PLXNC1;	GO:0043087~regulation of GTPase activity	8	71	11.2676056338028	0.00308386272097838	0.0291484332184783	1	1	0.91121276022603	0.999436947074871	0.258087407049204
down	TLR4; ADRB2; CD36; FPR2; CASP4; TLR6;	GO:1904646~cellular response to amyloid-beta	6	41	14.6341463414634	0.00315461703537734	0.0297456934846611	1	1	0.914428277407044	0.999436947074871	0.2633756965527
down	TLR4; NLRC4; PYCARD; PYHIN1; MNDA;	GO:0002218~activation of innate immune response	5	28	17.8571428571429	0.00325063872497755	0.0305048006363048	1	1	0.917972904651926	0.999436947074871	0.270097018243364
down	SASH3; GATA1; CORO1A; CCR2; P2RX7;	GO:0048873~homeostasis of number of cells within a tissue	5	28	17.8571428571429	0.00325063872497755	0.0305048006363048	1	1	0.917972904651926	0.999436947074871	0.270097018243364
down	RAB37; RAB27A; RAB31; RAB29; RAB24; RAB32; RAB20; RAB9B;	GO:0032482~Rab protein signal transduction	8	72	11.1111111111111	0.00333534031889571	0.0312251384140427	1	1	0.920707018435079	0.999436947074871	0.276475066348471
up	NRP1; TBX3; PDGFA; BMP2; CCL2; ELN; COL9A1; PAX6; VEGFC; NKX6-1; GAMT; HSPG2; LAMB1; LAMC2; LAMA1; NTN3; LAMB3; NTNG1; AGRN; EGFLAM; LAMA3; LAMA5;	GO:0009887~animal organ morphogenesis	22	111	19.8198198198198	0.00334150929584098	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	ZGLP1; LMO2; ARHGDIB; TCL1A; TNFRSF17; ID2; CLC; HLX; PDCD1; NFE2; SFRP5; GFI1B; CATSPERG; SLC22A16; GPR65; CATSPER1; PBXIP1; ODF3; SLC26A8; HEMGN; DKK2; PLEKHB1; TBX21; PRELID1; NOSIP; CHST2; CSF1R; MEF2C; EPHB1;	GO:0007275~multicellular organism development	29	513	5.65302144249513	0.00345323225192551	0.0322520408897176	1	1	0.924907801666898	0.999436947074871	0.285567513796773
down	LYN; HCLS1; SNRPN; PTK2B; LCN8; TIMP2;	GO:0009725~response to hormone	6	42	14.2857142857143	0.00351236438814895	0.0327265800336532	1	1	0.926879886531859	0.999436947074871	0.28976920025737
down	UBE2L6; RNF113A; UBB; TRIM21; ARRB1; CDC34; UBE2D1; ZBTB16; DCAF12; RNF130; DTX1; RNF135; RNF182; RNF149; NSMCE1; MED30; RNF157; FBXL15; ASB8; ATG3; RNF181; HERC5; RNF24; NOSIP; FBXO7; ISG15;	GO:0016567~protein ubiquitination	26	444	5.85585585585586	0.00352397447077091	0.0327571338512322	1	1	0.926879886531859	0.999436947074871	0.290039731283696
down	AQP9; SLC14A1; AQP10; UPK3A;	GO:0006833~water transport	4	17	23.5294117647059	0.00358496720408708	0.0330119228254576	1	1	0.928921472185013	0.999436947074871	0.292295695616656
down	TNF; IFNGR1; C5AR1; FPR2;	GO:0048143~astrocyte activation	4	17	23.5294117647059	0.00358496720408708	0.0330119228254576	1	1	0.928921472185013	0.999436947074871	0.292295695616656
down	SLC4A1; GATA1; RHAG; LYAR;	GO:0048821~erythrocyte development	4	17	23.5294117647059	0.00358496720408708	0.0330119228254576	1	1	0.928921472185013	0.999436947074871	0.292295695616656
down	PTPN6; BID; ID2; PSME1;	GO:2000045~regulation of G1/S transition of mitotic cell cycle	4	17	23.5294117647059	0.00358496720408708	0.0330119228254576	1	1	0.928921472185013	0.999436947074871	0.292295695616656
down	MYO1G; LIN7A; BAIAP3; CCL5; ANK1; CCR1; RAB27A; STX11; STX3;	GO:0006887~exocytosis	9	90	10	0.00364238611521894	0.0334622948715909	1	1	0.931036298579087	0.999436947074871	0.296283400640894
down	TNF; TIMP2; CDKN1C; BTG2; BTG1;	GO:0045930~negative regulation of mitotic cell cycle	5	29	17.2413793103448	0.00371528092339024	0.0337378397015483	1	1	0.933228378905365	0.999436947074871	0.298723142432726
down	TNF; CCL5; IL10RA; CRLF3; ADIPOR1;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	5	29	17.2413793103448	0.00371528092339024	0.0337378397015483	1	1	0.933228378905365	0.999436947074871	0.298723142432726
down	LYN; VAV1; EPOR; GRB2; RASGRP4;	GO:0046579~positive regulation of Ras protein signal transduction	5	29	17.2413793103448	0.00371528092339024	0.0337378397015483	1	1	0.933228378905365	0.999436947074871	0.298723142432726
down	FTL; EPB42; SLC11A1; STEAP4; SLC25A37;	GO:0055072~iron ion homeostasis	5	29	17.2413793103448	0.00371528092339024	0.0337378397015483	1	1	0.933228378905365	0.999436947074871	0.298723142432726
down	SNCA; DAXX; MT1L; MT1H; MT1F;	GO:0071280~cellular response to copper ion	5	29	17.2413793103448	0.00371528092339024	0.0337378397015483	1	1	0.933228378905365	0.999436947074871	0.298723142432726
up	CCL21; PDGFB; THBS1; CCL19; RARRES2; TREM2; CCL26;	GO:0050921~positive regulation of chemotaxis	7	17	41.1764705882353	0.00390163909251151	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	FOLR2; FOLR3; SLC19A1;	GO:0015884~folic acid transport	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	HLA-E; STAT5B; IL23R;	GO:0032819~positive regulation of natural killer cell proliferation	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	IL2RG; JAK3; IL21R;	GO:0038114~interleukin-21-mediated signaling pathway	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	CSF1R; PRTN3; PARD6A;	GO:0045217~cell-cell junction maintenance	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	PRKCB; NFAM1; CMTM3;	GO:0050861~positive regulation of B cell receptor signaling pathway	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	PLIN5; LRRK2; BRAT1;	GO:0051646~mitochondrion localization	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	AQP9; SLC14A1; AQP10;	GO:0071918~urea transmembrane transport	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	CST7; PTPRC; SYT11;	GO:1903979~negative regulation of microglial cell activation	3	8	37.5	0.00404738217458744	0.0358430331317068	1	1	0.94024377572176	0.999436947074871	0.317363043577814
down	DPM2; ASGR1; ASGR2; OST4; ST6GAL1;	GO:0018279~protein N-linked glycosylation via asparagine	5	30	16.6666666666667	0.00422561885887607	0.0370873512345998	1	1	0.940980831614305	0.999436947074871	0.328380542539523
down	UBE2L6; ISG15; PIN1; RNF135; HERC5;	GO:0032480~negative regulation of type I interferon production	5	30	16.6666666666667	0.00422561885887607	0.0370873512345998	1	1	0.940980831614305	0.999436947074871	0.328380542539523
down	TYROBP; CST3; LYN; AIF1; P2RX4;	GO:0048678~response to axon injury	5	30	16.6666666666667	0.00422561885887607	0.0370873512345998	1	1	0.940980831614305	0.999436947074871	0.328380542539523
down	GZMB; PTPN6; KIR3DL1; SLAMF7;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.00427541249329877	0.0371923051408203	1	1	0.941136394563054	0.999436947074871	0.329309830275611
down	SULT1B1; TPST2; SULT1A1; SULT1A2;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	4	18	22.2222222222222	0.00427541249329877	0.0371923051408203	1	1	0.941136394563054	0.999436947074871	0.329309830275611
down	TSPAN33; SORL1; TESC; ISCA2;	GO:0051604~protein maturation	4	18	22.2222222222222	0.00427541249329877	0.0371923051408203	1	1	0.941136394563054	0.999436947074871	0.329309830275611
down	ST6GAL1; ST3GAL2; ST8SIA4; ST3GAL6;	GO:0097503~sialylation	4	18	22.2222222222222	0.00427541249329877	0.0371923051408203	1	1	0.941136394563054	0.999436947074871	0.329309830275611
down	CYBB; GPX1; CYBA; NCF1; NCF2; SNCA; AIF1; NCF4; LRRK2;	GO:0034599~cellular response to oxidative stress	9	94	9.57446808510638	0.00473598944320075	0.0410138675257492	1	1	0.942961481301056	0.999436947074871	0.363146884892249
up	SH3PXD2B; TBX3; TLL1; COL2A1; IGF1; INHA; PTHLH; BMP2; BMP3; BMP1; PAX1; SOX9; CDH11; DLX5; EVC; TGFB2; NKX3-2; EXT1; FRZB; ALX4; DLL3; HOXD4; MMP16; HAPLN1; MMP14;	GO:0001501~skeletal system development	25	137	18.2481751824818	0.00475080355644641	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	WNT7A; NRP1; FGF10; TBX1; RAMP2; FN1; PDGFA; HRG; SERPINE1; FGF1; ITGAV; CCL2; CEACAM1; EFNA1; S100A7; APLNR; SOX18; COL15A1; MCAM; MEOX2; MMP14; VAV2; HSPG2; MFGE8; TGFBI; ECSCR; RASIP1; NRCAM; SOX17; TNFRSF12A; ESM1; TMEM100; APLN; HIF3A; PGF; VEGFC; RAMP3;	GO:0001525~angiogenesis	37	230	16.0869565217391	0.00476605256348839	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	LPXN; SPN; ARHGDIB; SEMA4D; SIPA1; PLXNC1;	GO:0007162~negative regulation of cell adhesion	6	45	13.3333333333333	0.00476687117478825	0.0410138675257492	1	1	0.943155906348747	0.999436947074871	0.363146884892249
down	PF4; GP1BA; ITGA2B; GATA1; MEF2C; NFE2;	GO:0045652~regulation of megakaryocyte differentiation	6	45	13.3333333333333	0.00476687117478825	0.0410138675257492	1	1	0.943155906348747	0.999436947074871	0.363146884892249
down	TNF; ALPL; CYBA; CCL5; CEBPB; P2RY13;	GO:0071407~cellular response to organic cyclic compound	6	45	13.3333333333333	0.00476687117478825	0.0410138675257492	1	1	0.943155906348747	0.999436947074871	0.363146884892249
down	LYN; FGR; CD19; CCR7; PTK2B;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	5	31	16.1290322580645	0.00478401900368164	0.0410715343285507	1	1	0.943155906348747	0.999436947074871	0.363657480967733
down	PECAM1; WAS; RHOG; ARHGAP4; ARHGEF1; ARHGDIB; CDC42EP3; RAC2;	GO:0007266~Rho protein signal transduction	8	77	10.3896103896104	0.00483972264495613	0.0412296465966751	1	1	0.943455178411685	0.999436947074871	0.365057445933158
down	UBB; PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1; MAP3K3; MYD88;	GO:0070498~interleukin-1-mediated signaling pathway	9	95	9.47368421052632	0.00504556509697951	0.0412296465966751	1	1	0.944191431059274	0.999436947074871	0.365057445933158
down	RNASE3; CAMP; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	GATA1; PTPN6; MEF2C; CLEC1B;	GO:0030220~platelet formation	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	TLR4; FFAR2; TNF; IL6R;	GO:0032722~positive regulation of chemokine production	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	IL2RG; STAT5A; STAT5B; JAK3;	GO:0038111~interleukin-7-mediated signaling pathway	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	CD74; GATA3; CD27; ZAP70;	GO:0045582~positive regulation of T cell differentiation	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	FCN1; IFITM1; IFITM2; TRIM10;	GO:0046597~negative regulation of viral entry into host cell	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	MTHFD2; FOLR2; SLC19A1; MTHFS;	GO:0046655~folic acid metabolic process	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	AR; ACTB; CLN3; STX8;	GO:1903076~regulation of protein localization to plasma membrane	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	GMFG; CSF1R; ARHGDIB; PTK2B;	GO:2000249~regulation of actin cytoskeleton reorganization	4	19	21.0526315789474	0.00505018710233296	0.0412296465966751	1	1	0.9443012079958	0.999436947074871	0.365057445933158
down	TNF; WNT1; GATA3; ZFP36L2; GPS2; TRIB3;	GO:0045599~negative regulation of fat cell differentiation	6	46	13.0434782608696	0.00525015645460591	0.0412296465966751	1	1	0.945028161829065	0.999436947074871	0.365057445933158
down	MFNG; PTK2B; LFNG;	GO:0002315~marginal zone B cell differentiation	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	DYSF; LYN; S100A12;	GO:0050663~cytokine secretion	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	TYROBP; TNF; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	SULT1B1; SULT1A1; SULT1A2;	GO:0051923~sulfation	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	CLN3; TMEM175; RAB20;	GO:0090385~phagosome-lysosome fusion	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	SLC24A4; RELT; CSF3R;	GO:0097186~amelogenesis	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	LILRA5; LGALS9; PYCARD;	GO:2001181~positive regulation of interleukin-10 secretion	3	9	33.3333333333333	0.00527309253308894	0.0412296465966751	1	1	0.94510457557674	0.999436947074871	0.365057445933158
down	AQP9; CRIP1; HP; JUND; TIMP2;	GO:0010033~response to organic substance	5	32	15.625	0.00539282531027951	0.0412296465966751	1	1	0.945593001713989	0.999436947074871	0.365057445933158
down	CD74; TOR2A; BAG1; HSPA1L; HSPA6;	GO:0051085~chaperone cofactor-dependent protein refolding	5	32	15.625	0.00539282531027951	0.0412296465966751	1	1	0.945593001713989	0.999436947074871	0.365057445933158
down	TLR4; TNFSF14; CYBA; TNFRSF8; CASP1; CASP5; MYD88; TLR8;	GO:0071260~cellular response to mechanical stimulus	8	79	10.126582278481	0.00556887925089078	0.0416289604838451	1	1	0.946369775811782	0.999436947074871	0.368593069442181
up	UGT1A9; UGT1A3; UGT2B28; UGT1A8; UGT1A10;	GO:0052697~xenobiotic glucuronidation	5	9	55.5555555555556	0.00560523590205064	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	TBX1; SOX9; FZD2; SIX1; TIFAB; MYO3A; FRZB; VANGL2;	GO:0090103~cochlea morphogenesis	8	24	33.3333333333333	0.00585788352061067	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PTPN2; GPS2; CARD16; CARD8;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	4	20	20	0.00591366261805804	0.0437900591604599	1	1	0.947646258087137	0.999436947074871	0.387727969408996
down	PARVG; RHOG; CYFIP2; RAC2;	GO:0030031~cell projection assembly	4	20	20	0.00591366261805804	0.0437900591604599	1	1	0.947646258087137	0.999436947074871	0.387727969408996
down	HLA-DRB1; MS4A1; SNCA; CUTC;	GO:0051262~protein tetramerization	4	20	20	0.00591366261805804	0.0437900591604599	1	1	0.947646258087137	0.999436947074871	0.387727969408996
down	TLR4; CD14; FASLG; LY96;	GO:0070266~necroptotic process	4	20	20	0.00591366261805804	0.0437900591604599	1	1	0.947646258087137	0.999436947074871	0.387727969408996
down	DPM2; ASGR2; CTSA; PIN1; LRRK2; RNF149; PYCARD; FBXO7;	GO:0031647~regulation of protein stability	8	80	10	0.00596341569141845	0.0440754708621379	1	1	0.947950051718261	0.999436947074871	0.390255074913277
down	PIK3CD; CD160; GATA3; PIK3CG; PIK3R5;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.00605435265936238	0.0443309397702288	1	1	0.948261787666539	0.999436947074871	0.392517059548152
down	BIN1; CD22; SNX17; PACSIN1; RAB20;	GO:0030100~regulation of endocytosis	5	33	15.1515151515152	0.00605435265936238	0.0443309397702288	1	1	0.948261787666539	0.999436947074871	0.392517059548152
down	ARRB1; GPR20; GPR65; GPR35; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.00605435265936238	0.0443309397702288	1	1	0.948261787666539	0.999436947074871	0.392517059548152
down	ADAM8; CCL5; XCL2; CCL23; CCL4;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.00605435265936238	0.0443309397702288	1	1	0.948261787666539	0.999436947074871	0.392517059548152
down	LGALS9; CYBA; CHI3L1; SNCA; MYD88;	GO:0070555~response to interleukin-1	5	33	15.1515151515152	0.00605435265936238	0.0443309397702288	1	1	0.948261787666539	0.999436947074871	0.392517059548152
down	UBB; PSMB8; PSMB9; PSMB10; PSMB3; UBE2D1; PSME1; PSMF1;	GO:0031145~anaphase-promoting complex-dependent catabolic process	8	81	9.87654320987654	0.00637882466952644	0.0466199602241226	1	1	0.949594727583311	0.999436947074871	0.412784610438453
up	UGT1A9; UGT2B17; UGT2B7; UGT1A4; UGT1A3; UGT1A10;	GO:0052695~cellular glucuronidation	6	14	42.8571428571429	0.00640217359148076	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	MYO1G; CD70; CD8A;	GO:0002456~T cell mediated immunity	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	ALDOC; PFKFB4; FBP1;	GO:0006000~fructose metabolic process	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	TESPA1; VNN1; ADAM8;	GO:0033089~positive regulation of T cell differentiation in thymus	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	RAB32; BLOC1S3; AP1M1;	GO:0035646~endosome to melanosome transport	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	FGR; FCER1G; SYK;	GO:0043306~positive regulation of mast cell degranulation	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	NEURL1; NCF1; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	MPP1; GUK1; CARD11;	GO:0046037~GMP metabolic process	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	ZAP70; SYK; NKAP;	GO:0046638~positive regulation of alpha-beta T cell differentiation	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	TLR4; CD14; CD36;	GO:0071223~cellular response to lipoteichoic acid	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	LGALS9; SYK; CLEC7A;	GO:0071639~positive regulation of monocyte chemotactic protein-1 production	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	MMP9; TNFRSF1B; MMP8;	GO:0150077~regulation of neuroinflammatory response	3	10	30	0.00669850705324504	0.0478882358788355	1	1	0.950887824187354	0.999436947074871	0.424014235464781
down	BAIAP3; NADK; HLA-DRB1; ARRB1; GPR27;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	5	34	14.7058823529412	0.00677088061389552	0.048317790515131	1	1	0.951083339315182	0.999436947074871	0.427817618014935
down	TNF; CSNK2B; MEF2C; RGCC;	GO:0043537~negative regulation of blood vessel endothelial cell migration	4	21	19.047619047619	0.00687001635813522	0.048727928280066	1	1	0.951483059132073	0.999436947074871	0.431449078803637
down	FGR; RNF135; TREML2; TREML4;	GO:0045088~regulation of innate immune response	4	21	19.047619047619	0.00687001635813522	0.048727928280066	1	1	0.951483059132073	0.999436947074871	0.431449078803637
down	MEFV; TRIM21; TFEB; LRRK2; PLEKHF1; PIM2;	GO:0010508~positive regulation of autophagy	6	49	12.2448979591837	0.00691510274167773	0.048727928280066	1	1	0.95168739351608	0.999436947074871	0.431449078803637
down	CLEC1B; MAP3K3; MAP2K3; STRADB; STK10; MAP4K1;	GO:0023014~signal transduction by protein phosphorylation	6	49	12.2448979591837	0.00691510274167773	0.048727928280066	1	1	0.95168739351608	0.999436947074871	0.431449078803637
down	CTSH; TRIM21; SNCA; SERF2; PYHIN1; RNF5;	GO:0031648~protein destabilization	6	49	12.2448979591837	0.00691510274167773	0.048727928280066	1	1	0.95168739351608	0.999436947074871	0.431449078803637
down	TNF; HLA-DRA; C5AR1; METTL23; RP9; JAKMIP1;	GO:0050890~cognition	6	49	12.2448979591837	0.00691510274167773	0.048727928280066	1	1	0.95168739351608	0.999436947074871	0.431449078803637
down	ELANE; LCP1; MMP9; TIMP2; MMP8; CTSS; ADAM8;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00739653217924763	0.0519342223728601	1	1	0.953673523728636	0.999436947074871	0.459838396419578
down	UBE2L6; ISG15; UBB; RPA2; POLD4;	GO:0019985~translesion synthesis	5	35	14.2857142857143	0.00754464749183514	0.0527045478321063	1	1	0.954154357420564	0.999436947074871	0.466659047768852
down	TNF; PF4; IFI6; GATA1; STRADB;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	35	14.2857142857143	0.00754464749183514	0.0527045478321063	1	1	0.954154357420564	0.999436947074871	0.466659047768852
down	HP; GPX1; HBB; HBA1; PTK2B; TXNIP;	GO:0042542~response to hydrogen peroxide	6	50	12	0.00754645483964289	0.0527045478321063	1	1	0.954154357420564	0.999436947074871	0.466659047768852
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.00779869634842623	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	STX10; STX8; STX11; STX3;	GO:0048278~vesicle docking	4	22	18.1818181818182	0.00792321976031829	0.055237766130446	1	1	0.95569549104854	0.999436947074871	0.489088786520423
down	CSF1R; ADRB2; SNCA; TCL1A; CAMK1; DAZAP2;	GO:0071902~positive regulation of protein serine/threonine kinase activity	6	51	11.7647058823529	0.00821830638430432	0.0569698697070504	1	1	0.956813835805124	0.999436947074871	0.504425258209169
down	TNFRSF1B; HLA-F; SNCA; KIR3DL2; LRRK2; SORL1;	GO:1901215~negative regulation of neuron death	6	51	11.7647058823529	0.00821830638430432	0.0569698697070504	1	1	0.956813835805124	0.999436947074871	0.504425258209169
down	OPRL1; TRPV2; PNOC;	GO:0007600~sensory perception	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	PIK3CD; PIK3CG; CXCR3;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	PSENEN; PRELID1; PSME1;	GO:0010950~positive regulation of endopeptidase activity	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	ALOX5; ALOX5AP; SYK;	GO:0019370~leukotriene biosynthetic process	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	IFITM1; IFNAR2; IFITM2;	GO:0035456~response to interferon-beta	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	IFIT2; GATA3; PYHIN1;	GO:0035457~cellular response to interferon-alpha	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	GSDMD; TSPAN33; P2RX7;	GO:0046931~pore complex assembly	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	LYN; CD19; BLK;	GO:0050855~regulation of B cell receptor signaling pathway	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	TPP1; TINF2; TERF2IP;	GO:0070198~protein localization to chromosome, telomeric region	3	11	27.2727272727273	0.0083310465619415	0.0569698697070504	1	1	0.957403233717378	0.999436947074871	0.504425258209169
down	FLI1; C3AR1; NFE2; XCL2; F5;	GO:0008015~blood circulation	5	36	13.8888888888889	0.00837784476248582	0.056996180852051	1	1	0.957403233717378	0.999436947074871	0.504658223567505
down	STX11; GCA; OTOF; MX2; DYSF;	GO:0061025~membrane fusion	5	36	13.8888888888889	0.00837784476248582	0.056996180852051	1	1	0.957403233717378	0.999436947074871	0.504658223567505
up	APOA1; NEFL; TNC; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	4	6	66.6666666666667	0.00846668631587488	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	SDCBP; ARPC1B; LYN; MMP9; EPHB1; ACTB; APH1B; PSENEN;	GO:0048013~ephrin receptor signaling pathway	8	86	9.30232558139535	0.00879282624210631	0.0570412324035439	1	1	0.958974034757111	0.999436947074871	0.505057121100734
up	NRP1; RAMP2; THBS1; CDH13; E2F7; ESM1; LOXL2; VEGFC; PGF;	GO:0002040~sprouting angiogenesis	9	32	28.125	0.00880679862201184	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	OAZ2; PDE6G; OAZ1; CLN3; TXNIP; NOSIP;	GO:0043086~negative regulation of catalytic activity	6	52	11.5384615384615	0.00893202734571008	0.0570412324035439	1	1	0.959644645970228	0.999436947074871	0.505057121100734
down	LGALS9; RGS2; DSG1; KLF1;	GO:0060135~maternal process involved in female pregnancy	4	23	17.3913043478261	0.0090770287246178	0.057308542051431	1	1	0.960341555662291	0.999436947074871	0.507423946562169
down	RAB29; B3GAT3; OAZ2; OAZ1;	GO:0090316~positive regulation of intracellular protein transport	4	23	17.3913043478261	0.0090770287246178	0.057308542051431	1	1	0.960341555662291	0.999436947074871	0.507423946562169
down	BEST1; SLC4A1; SLC4A10; SLC26A8; NMUR1;	GO:0006821~chloride transport	5	37	13.5135135135135	0.00927261177134631	0.0583358551758939	1	1	0.961066341742036	0.999436947074871	0.516520029995983
down	CNR2; OPRL1; CCR2; P2RX4; P2RX7; PROK2;	GO:0019233~sensory perception of pain	6	53	11.3207547169811	0.00968897173504757	0.060760824341638	1	1	0.962606512161494	0.999436947074871	0.537991304265518
down	TNF; RHOG; STX3; CNPY4; STAC3; RANGRF;	GO:1903078~positive regulation of protein localization to plasma membrane	6	53	11.3207547169811	0.00968897173504757	0.060760824341638	1	1	0.962606512161494	0.999436947074871	0.537991304265518
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.00974745490481166	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PSAP; PIP4K2A; NLRP6; LRRK2; TRIB3; KAT8; PYCARD;	GO:0010506~regulation of autophagy	7	70	10	0.00982274968693242	0.0614038978839718	1	1	0.963011820166615	0.999436947074871	0.543685235799981
down	FFAR2; DYSF; GPX1; PSMB8; CEBPD; STEAP4; RETN;	GO:0045444~fat cell differentiation	7	70	10	0.00982274968693242	0.0614038978839718	1	1	0.963011820166615	0.999436947074871	0.543685235799981
down	TNF; HCLS1; SNCA; ARRB1; TCL1A; CAMK1; TERF2IP; SH2D3C;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	8	88	9.09090909090909	0.00992846099053246	0.0617701085676798	1	1	0.963425751746313	0.999436947074871	0.546927755392149
down	WNT1; PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1; PARD6A;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	8	88	9.09090909090909	0.00992846099053246	0.0617701085676798	1	1	0.963425751746313	0.999436947074871	0.546927755392149
down	SULT1B1; SULT1A1; SULT1A2;	GO:0006068~ethanol catabolic process	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	CYP27A1; SCARF1; SNX17;	GO:0006707~cholesterol catabolic process	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	BNIP3L; ARL6IP5; PRELID1;	GO:0010917~negative regulation of mitochondrial membrane potential	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	WNT1; BID; GRB2;	GO:0042770~signal transduction in response to DNA damage	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	PRKCB; CD36; UNC119;	GO:0042953~lipoprotein transport	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	MMP9; MAPRE2; IQSEC1;	GO:0051549~positive regulation of keratinocyte migration	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	MEF2C; PTK2B; KLF2;	GO:0071498~cellular response to fluid shear stress	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	LYN; GATA1; LILRB1;	GO:0097028~dendritic cell differentiation	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	TNF; ITGB2; FUT7;	GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	GATA3; WAS; PIN1;	GO:2000146~negative regulation of cell motility	3	12	25	0.0101768358587215	0.0623291566923568	1	1	0.964722130869542	0.999436947074871	0.551877705183006
down	CD40LG; SYK; PKN1; MAP4K1; DAXX;	GO:0007257~activation of JUN kinase activity	5	38	13.1578947368421	0.0102310307975796	0.0624664799628617	1	1	0.964722130869542	0.999436947074871	0.553093599243125
down	TYROBP; ITGB2; ITGAM; SNCA; DAXX;	GO:1901216~positive regulation of neuron death	5	38	13.1578947368421	0.0102310307975796	0.0624664799628617	1	1	0.964722130869542	0.999436947074871	0.553093599243125
down	PSMB8; PSMB9; PSMB10; PSMB3;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	4	24	16.6666666666667	0.0103349757528017	0.0630032940465371	1	1	0.965173462860592	0.999436947074871	0.557846683358653
up	CCL26; CCL18; CCL2; CCL24; CCL14; CCL21; CCL19; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	9	33	27.2727272727273	0.0103431888981507	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	UBB; PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	7	71	9.85915492957746	0.010510462846382	0.0639739007925296	1	1	0.966106899478445	0.999436947074871	0.566440674550565
up	INHBA; ITGB4; ITGA3; HMGA2; ITGA8;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.0105238997856624	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	GMFG; PTPRC; TRIM27; SNCA; PKN1; TESC; TRIB3;	GO:0006469~negative regulation of protein kinase activity	7	72	9.72222222222222	0.0112324934140884	0.0680848330039401	1	1	0.96863729994853	0.999436947074871	0.602839880883392
down	RGS6; RGS19; NLRP12; INPP5D; RGS18;	GO:0009968~negative regulation of signal transduction	5	39	12.8205128205128	0.0112551224447002	0.0680848330039401	1	1	0.96863729994853	0.999436947074871	0.602839880883392
down	ISG15; ADRB2; ALOX5; MEF2C; P2RX7;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.0112551224447002	0.0680848330039401	1	1	0.96863729994853	0.999436947074871	0.602839880883392
down	LILRA5; CSF1R; FCGR1A; CCL5; UNC119;	GO:0061098~positive regulation of protein tyrosine kinase activity	5	39	12.8205128205128	0.0112551224447002	0.0680848330039401	1	1	0.96863729994853	0.999436947074871	0.602839880883392
down	SRGN; CTSS; CLN3; APH1B; P2RX7; PSENEN;	GO:0016485~protein processing	6	55	10.9090909090909	0.011337852682178	0.0684799335581013	1	1	0.969180410293329	0.999436947074871	0.606338198504201
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0114483274792085	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0114483274792085	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	DOK2; GRB2; GRAP; DOK3; RASGRP2; DOK1; RASSF1;	GO:0007265~Ras protein signal transduction	7	73	9.58904109589041	0.0119897546697635	0.0723063119041565	1	1	0.971492110735293	0.999436947074871	0.640217894826834
down	SLC11A1; BTK; CLEC4A;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	VNN1; TREM1; HP;	GO:0002526~acute inflammatory response	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	TNFRSF1B; RGS2; P2RX4;	GO:0010614~negative regulation of cardiac muscle hypertrophy	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	SLC43A1; SLC6A15; SLC43A2;	GO:0015804~neutral amino acid transport	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	TRIM21; IRF7; ZBP1;	GO:0032479~regulation of type I interferon production	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	TLR4; IRF5; IRF7;	GO:0032727~positive regulation of interferon-alpha production	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	LRRK2; SLC4A10; C12orf10;	GO:0035641~locomotory exploration behavior	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	TLR4; SLC11A1; TLR1;	GO:0042116~macrophage activation	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	XKR8; RHOG; RAC2;	GO:0043652~engulfment of apoptotic cell	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	PF4; HCLS1; ID2;	GO:0045651~positive regulation of macrophage differentiation	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	ITGB2; ITGAM; PECAM1;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	BIN1; PIN1; SORL1;	GO:1902430~negative regulation of amyloid-beta formation	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
down	SLC43A1; SLC43A2; SLC7A7;	GO:1902475~L-alpha-amino acid transmembrane transport	3	13	23.0769230769231	0.0122407966461973	0.0723771615230791	1	1	0.972560781787142	0.999436947074871	0.640845214803215
up	TNFSF11; PDGFB; PGR; SERPINB3;	GO:0038001~paracrine signaling	4	7	57.1428571428571	0.0123774227614133	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	UGT1A9; UGT1A3; UGT1A8; UGT1A10;	GO:0052696~flavonoid glucuronidation	4	7	57.1428571428571	0.0123774227614133	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	TNF; WNT1; HCLS1; TRIM27; TRIM21; NFAM1; RGCC; BEX1; PYCARD;	GO:0051091~positive regulation of DNA-binding transcription factor activity	9	111	8.10810810810811	0.0124485377589175	0.0734949706727683	1	1	0.972876548274735	0.999436947074871	0.650742572333783
down	TNFSF12; OAZ2; TNF; OAZ1; SORL1; RILP; VPS28;	GO:0045732~positive regulation of protein catabolic process	7	74	9.45945945945946	0.0127831501190251	0.0738570261592129	1	1	0.973533342568929	0.999436947074871	0.653948300785945
down	GPS2; DUSP6; LAX1; DUSP2;	GO:0000188~inactivation of MAPK activity	4	26	15.3846153846154	0.0131762612694399	0.0738570261592129	1	1	0.974586950082532	0.999436947074871	0.653948300785945
down	TNNI2; RCSD1; STAC3; TNNI3;	GO:0003009~skeletal muscle contraction	4	26	15.3846153846154	0.0131762612694399	0.0738570261592129	1	1	0.974586950082532	0.999436947074871	0.653948300785945
down	PPT1; BTG2; CLN3; NRGN;	GO:0008306~associative learning	4	26	15.3846153846154	0.0131762612694399	0.0738570261592129	1	1	0.974586950082532	0.999436947074871	0.653948300785945
down	CHST13; B3GALT6; CHST12; CHST7;	GO:0030206~chondroitin sulfate biosynthetic process	4	26	15.3846153846154	0.0131762612694399	0.0738570261592129	1	1	0.974586950082532	0.999436947074871	0.653948300785945
down	TLR4; IRF5; RNF135; IRF7;	GO:0032728~positive regulation of interferon-beta production	4	26	15.3846153846154	0.0131762612694399	0.0738570261592129	1	1	0.974586950082532	0.999436947074871	0.653948300785945
down	SLC43A1; SLC6A12; SLC43A2; SLC6A15; SLC7A7;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.0135080723058862	0.0754456538448078	1	1	0.97495793864366	0.999436947074871	0.668014401597218
down	AIP; SULT1B1; AOC2; CES1; SULT1A1; SULT1A2; S100A12; GUK1;	GO:0006805~xenobiotic metabolic process	8	94	8.51063829787234	0.0139892960600251	0.0780225703659839	1	1	0.976136372896654	0.999436947074871	0.690831055176765
up	NTRK1; CCL2; ADCYAP1; DRD1; TSHZ3; NLGN2; NRXN1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	7	23	30.4347826086957	0.0143345731996193	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	CHST7; NAGK; CHST2;	GO:0006044~N-acetylglucosamine metabolic process	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	SLC11A1; ATP6V0E2; ATP6V0D1;	GO:0007035~vacuolar acidification	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	CSF1R; PLEK; CCR7;	GO:0031529~ruffle organization	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	MEFV; CD33; CX3CR1;	GO:0032691~negative regulation of interleukin-1 beta production	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	MMP8; JAK3; IL23R;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	EPB42; FAM210B; KLF2;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	IL27; CLEC7A; TLR8;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	CD33; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	PTPRC; PTPN2; SH3BP5;	GO:0061099~negative regulation of protein tyrosine kinase activity	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	FASLG; CDC34; DUSP6;	GO:0070848~response to growth factor	3	14	21.4285714285714	0.0145267353432532	0.0797753119688152	1	1	0.976981512613447	0.999436947074871	0.706350261032921
down	PTGER2; DSG1; CATSPERG; CATSPER1; TXNIP;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.0147406265047434	0.0806525389340242	1	1	0.977423585696078	0.999436947074871	0.714117444646101
down	GNGT2; ARRB1; UNC119; PLEKHB1;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0147654993212067	0.0806525389340242	1	1	0.977423585696078	0.999436947074871	0.714117444646101
down	KRT1; KRT10; KRT2; EPB42;	GO:0018149~peptide cross-linking	4	27	14.8148148148148	0.0147654993212067	0.0806525389340242	1	1	0.977423585696078	0.999436947074871	0.714117444646101
down	PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1; FBXL15; FBXL13;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	8	95	8.42105263157895	0.0147685218800858	0.0806525389340242	1	1	0.977423585696078	0.999436947074871	0.714117444646101
down	BTG2; STX3; PTK2B; BLOC1S3; DTNBP1; EHD1; BLOC1S4; LYN; GPM6A;	GO:0031175~neuron projection development	9	115	7.82608695652174	0.0151652048571668	0.0827040020781966	1	1	0.978349834059685	0.999436947074871	0.732281604605163
down	SLC11A1; PPP2R3C; STRADB; RGCC; MAP2K3; STK10; MAP3K3; MAP4K1;	GO:0032147~activation of protein kinase activity	8	96	8.33333333333333	0.0155787682786256	0.0847243663506996	1	1	0.979336820020905	0.999436947074871	0.750170407494733
down	MBP; CASP5; ACTB; BASP1; PADI2;	GO:0021762~substantia nigra development	5	43	11.6279069767442	0.0160462383789269	0.0870259438702631	1	1	0.979854987650546	0.999436947074871	0.77054914173731
down	MMP9; MMP8; PRTN3; CTSS; MMP25;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.0160462383789269	0.0870259438702631	1	1	0.979854987650546	0.999436947074871	0.77054914173731
down	IL6R; IFITM1; JUND; CEBPB; CEBPD; MEF2C;	GO:0045669~positive regulation of osteoblast differentiation	6	60	10	0.016307147228904	0.0883191500055794	1	1	0.980390720284581	0.999436947074871	0.781999507379341
down	SLFN14; ZFP36L2; LSM6; NUDT16;	GO:0006402~mRNA catabolic process	4	28	14.2857142857143	0.0164706692071641	0.0889597133551776	1	1	0.980944926457721	0.999436947074871	0.787671213049056
down	ATP6V0D1; ATP6V0E2; ATP6V0B; RAB20;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.0164706692071641	0.0889597133551776	1	1	0.980944926457721	0.999436947074871	0.787671213049056
down	ARSG; CHST7; CHST2;	GO:0006790~sulfur compound metabolic process	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	CCL5; C5AR1; C3AR1;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	RAC2; PPP2R3C; RHOG;	GO:0030865~cortical cytoskeleton organization	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	SASH3; CCR2; CARD11;	GO:0032743~positive regulation of interleukin-2 production	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	ADPRM; NUDT18; NUDT16;	GO:0034656~nucleobase-containing small molecule catabolic process	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	CATSPERG; CATSPER1; HVCN1;	GO:0035036~sperm-egg recognition	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	LILRB1; SYT11; PACSIN1;	GO:0045806~negative regulation of endocytosis	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	TNF; TNFRSF1B; ADAM8;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	TLR4; FCER2; LRRK2;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	LTA; TNF; LYN;	GO:0060252~positive regulation of glial cell proliferation	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	HLA-G; ALOX5AP; STEAP4;	GO:0070207~protein homotrimerization	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	PLEK; AZU1; PRSS33;	GO:0070528~protein kinase C signaling	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	CYFIP2; NLRC4; PYCARD;	GO:0097202~activation of cysteine-type endopeptidase activity	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
down	LILRB2; PAIP2; CALB2;	GO:1900271~regulation of long-term synaptic potentiation	3	15	20	0.0170374260269646	0.0901630674805177	1	1	0.982112718036837	0.999436947074871	0.798326006863981
up	SH3PXD2B; FOXE1; TGFB2; COLEC10;	GO:1904888~cranial skeletal system development	4	8	50	0.0172766454021592	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	HLA-H; HLA-E; HLA-G; HLA-F;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	4	29	13.7931034482759	0.018294121687531	0.0923395205075376	1	1	0.984717791559481	0.999436947074871	0.817596858031098
down	TNF; SYK; RBCK1; PYCARD;	GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway	4	29	13.7931034482759	0.018294121687531	0.0923395205075376	1	1	0.984717791559481	0.999436947074871	0.817596858031098
down	WNT1; ZFP36L2; STAT5B; NKAP;	GO:0033077~T cell differentiation in thymus	4	29	13.7931034482759	0.018294121687531	0.0923395205075376	1	1	0.984717791559481	0.999436947074871	0.817596858031098
down	CDKN2D; HHEX; FBXO7; CDKN1C;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	4	29	13.7931034482759	0.018294121687531	0.0923395205075376	1	1	0.984717791559481	0.999436947074871	0.817596858031098
down	LYN; PTPN6; SYK; EPHB1;	GO:0070372~regulation of ERK1 and ERK2 cascade	4	29	13.7931034482759	0.018294121687531	0.0923395205075376	1	1	0.984717791559481	0.999436947074871	0.817596858031098
down	PSMB8; PSMB9; PSMB10; PSMB3; UBE2D1; PSME1; PSMF1;	GO:1901990~regulation of mitotic cell cycle phase transition	7	80	8.75	0.0183514097216836	0.0925099269559742	1	1	0.984717791559481	0.999436947074871	0.819105678697095
down	FPR1; CCR3; GNAZ; CYSLTR1; ADRB2; GNAI2;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	6	62	9.67741935483871	0.018659072351259	0.0935809598024876	1	1	0.985432909781384	0.999436947074871	0.828588867318223
down	WNT1; CCR1; CCR2; ZFP36L2; CX3CR1; HHEX;	GO:0009611~response to wounding	6	62	9.67741935483871	0.018659072351259	0.0935809598024876	1	1	0.985432909781384	0.999436947074871	0.828588867318223
down	UBB; GPM6A; LRRK2; DTNBP1; PACSIN1; HCLS1;	GO:0048812~neuron projection morphogenesis	6	62	9.67741935483871	0.018659072351259	0.0935809598024876	1	1	0.985432909781384	0.999436947074871	0.828588867318223
down	P2RX1; MEF2C; LRRK2; P2RX5; P2RX4; P2RX7;	GO:0060079~excitatory postsynaptic potential	6	62	9.67741935483871	0.018659072351259	0.0935809598024876	1	1	0.985432909781384	0.999436947074871	0.828588867318223
up	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	SNAI2; CXCL6; ACKR1;	GO:0032642~regulation of chemokine production	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	CEACAM1; PTPRG; TENM3;	GO:1903385~regulation of homophilic cell adhesion	3	4	75	0.0187180305263801	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	TNF; TNFRSF1B; CRIP1; PYCARD; BCL2A1;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	5	45	11.1111111111111	0.0188831711897448	0.0944639047303773	1	1	0.985432909781384	0.999436947074871	0.836406679181327
down	NLRP6; NLRP12; TANK; PYCARD; CARD8;	GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling	5	45	11.1111111111111	0.0188831711897448	0.0944639047303773	1	1	0.985432909781384	0.999436947074871	0.836406679181327
down	AR; HRH2; RILPL2;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	ST8SIA4; ST3GAL6; NAGA;	GO:0009311~oligosaccharide metabolic process	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	MT1H; MT1F; MT1L;	GO:0010273~detoxification of copper ion	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	CST7; CST3; PI16;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	SLFN14; DEDD2; EXOSC5;	GO:0016075~rRNA catabolic process	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	GPX1; ALOX5; ALOX5AP;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	CD4; ALPL; CDKN2D;	GO:0033280~response to vitamin D	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	TNF; LCK; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	BLOC1S3; DTNBP1; BLOC1S4;	GO:0048490~anterograde synaptic vesicle transport	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	CCR7; RASSF2; CARD11;	GO:0048872~homeostasis of number of cells	3	16	18.75	0.0197746887387217	0.0976810001515749	1	1	0.987757044002566	0.999436947074871	0.864891634419346
down	PSMB8; PSMB9; PSMB10; PSMB3; PSME1; PSMF1;	GO:0038061~NIK/NF-kappaB signaling	6	63	9.52380952380952	0.0199175903763139	0.0982634446168962	1	1	0.987757044002566	0.999436947074871	0.870048741172845
down	AIP; TIMM17B; BID; FBXO7;	GO:0006626~protein targeting to mitochondrion	4	30	13.3333333333333	0.0202379671227835	0.0992215545221753	1	1	0.988597688295334	0.999436947074871	0.878532082259079
down	LCK; MT1H; MT1F; MT1L;	GO:0006882~cellular zinc ion homeostasis	4	30	13.3333333333333	0.0202379671227835	0.0992215545221753	1	1	0.988597688295334	0.999436947074871	0.878532082259079
down	NEURL1; CCR7; GPM6A; MIEN1;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.0202379671227835	0.0992215545221753	1	1	0.988597688295334	0.999436947074871	0.878532082259079
down	TNF; MEF2C; CLN3; LRRK2;	GO:0051966~regulation of synaptic transmission, glutamatergic	4	30	13.3333333333333	0.0202379671227835	0.0992215545221753	1	1	0.988597688295334	0.999436947074871	0.878532082259079
down	TNF; PRKCB; JUND; USF1; PTAFR; STAT5A; ZFP36L2; STAT5B; IRX6; IRF9; CREB5; HLX; PKN1; SMARCD3; NFE4; OLIG1; THAP3; ISL2; ZNF524; TSC22D3; THAP7; SP110; KLF2; BATF; RUNX3; TCF7; KLF1; NFE2; FLI1; ZNF101; SPI1; ARID5A; SPIB; ASCL2; LYL1;	GO:0006357~regulation of transcription by RNA polymerase II	35	747	4.68540829986613	0.0202715085088041	0.0992622309546921	1	1	0.988597688295334	0.999436947074871	0.87889224141129
down	JUND; BTG2; HHEX; STAT5B; STAT5A;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.022031104304105	0.107744156870325	1	1	0.991399693684727	0.999436947074871	0.953993302588098
up	FOXE1; FGF1; CASR; MCAM; FAT1; SIX2; DKK3; SIX4; LYVE1; IGF2BP2; SOX17; FOXL2; FOXQ1; FOXD4L4; FOXD4L5; FBN2; FOXA3; FOXD4; FOXD1; FOXI2; SOX18;	GO:0009653~anatomical structure morphogenesis	21	127	16.5354330708661	0.0221060655413041	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	CCR2; IFNAR2; STAT5B; STAT5A;	GO:0007259~receptor signaling pathway via JAK-STAT	4	31	12.9032258064516	0.0223040765761851	0.108673642004411	1	1	0.99235126281188	0.999436947074871	0.962223192899837
down	TNFSF12; PTP4A3; ITGB2; PECAM1;	GO:0043542~endothelial cell migration	4	31	12.9032258064516	0.0223040765761851	0.108673642004411	1	1	0.99235126281188	0.999436947074871	0.962223192899837
down	IFI6; VAV1; LRRK2; P2RX7;	GO:0072593~reactive oxygen species metabolic process	4	31	12.9032258064516	0.0223040765761851	0.108673642004411	1	1	0.99235126281188	0.999436947074871	0.962223192899837
up	FGF10; NTF3; VEGFC; ARTN; PGF;	GO:0050930~induction of positive chemotaxis	5	14	35.7142857142857	0.0223994893387971	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	TBX1; TFAP2A; MMP14; MMP16; SIX1; NODAL; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.0227199852654792	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	ALOX5; ALOX5AP; DPEP2;	GO:0006691~leukotriene metabolic process	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	GP1BA; GP9; GP5;	GO:0007597~blood coagulation, intrinsic pathway	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	MFNG; DTX1; LFNG;	GO:0008593~regulation of Notch signaling pathway	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	IFIT2; PIM2; BID;	GO:0008637~apoptotic mitochondrial changes	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	ARHGAP4; KIAA0319; DRAXIN;	GO:0030517~negative regulation of axon extension	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	PTPN6; PIP4K2A; FLI1;	GO:0035855~megakaryocyte development	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	TPP1; NAALADL1; CPQ;	GO:0043171~peptide catabolic process	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	CD40LG; BATF; AICDA;	GO:0045190~isotype switching	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	LTA; CXCR5; LTB;	GO:0048535~lymph node development	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
down	AIF1; CXCR4; STX3;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0227394633793779	0.109171520143173	1	1	0.993401369968295	0.999436947074871	0.96663152856908
up	IDO1; TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.023228210726105	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	RAMP2; PXDN; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	4	9	44.4444444444444	0.023228210726105	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	KCNE1; KCNQ1; KCNAB2; SLC24A4; TMEM175; KCNK13; KCNH8; KCNH3; KCNA3;	GO:0071805~potassium ion transmembrane transport	9	125	7.2	0.0238306095801437	0.109849890819607	1	1	0.995659100354587	0.999436947074871	0.972637989622643
up	CCL24; HRH1; CCL11; CCL13; CCL18; CCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.0240139747845733	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PRF1; KCNA3; GSDMD; RNF135; SHKBP1; EHD1; NLRC4; PYCARD;	GO:0051260~protein homooligomerization	8	105	7.61904761904762	0.0243702620350402	0.112205937144939	1	1	0.996874801331821	0.999436947074871	0.993499004087299
down	PRKCB; PTPN2; GRB14; ENHO;	GO:0046627~negative regulation of insulin receptor signaling pathway	4	32	12.5	0.0244940837727601	0.112512543685155	1	1	0.996874801331821	0.999436947074871	0.996213773912334
down	AIF1; LSM10; RGCC; CCND3;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	4	32	12.5	0.0244940837727601	0.112512543685155	1	1	0.996874801331821	0.999436947074871	0.996213773912334
down	ADRB2; P2RX4; P2RX7;	GO:0002028~regulation of sodium ion transport	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	FUT7; SIRPG; SIRPB1;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	ARL6IP5; SCIMP; CARD9;	GO:0032874~positive regulation of stress-activated MAPK cascade	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	GPR171; ZBTB16; PTK2B;	GO:0045638~negative regulation of myeloid cell differentiation	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	MT1F; MT1H; MT1L;	GO:0045926~negative regulation of growth	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	TCF7; ID2; HLX;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	GPX1; UBB; PSME1;	GO:0061136~regulation of proteasomal protein catabolic process	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	PSAP; CASP1; TBX21;	GO:0071310~cellular response to organic substance	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	PDXP; P2RX4; P2RX7;	GO:0071318~cellular response to ATP	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
down	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.0259318794085988	0.117741512511097	1	1	0.999436947074871	0.999436947074871	1
up	COL2A1; BMP2; SOX9; DLX1; DLX5; TNMD; TMEM100; ADAMTS7;	GO:0071773~cellular response to BMP stimulus	8	33	24.2424242424242	0.0260928789971765	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	TPP1; SULT1B1; UPK3A; ALDOC; CES1; GSTK1;	GO:0030855~epithelial cell differentiation	6	68	8.82352941176471	0.027076017870137	0.122794581620967	1	1	0.999436947074871	0.999436947074871	1
down	STK10; MAP2K3; MAP4K1; MAP3K3; STRADB;	GO:0031098~stress-activated protein kinase signaling cascade	5	50	10	0.027359461323165	0.123794478622192	1	1	0.999436947074871	0.999436947074871	1
down	LCK; PTPRC; CCR7; P2RX7; PLCB2;	GO:0051209~release of sequestered calcium ion into cytosol	5	50	10	0.027359461323165	0.123794478622192	1	1	0.999436947074871	0.999436947074871	1
up	MUC2; MUC6; MUC13; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	5	15	33.3333333333333	0.0277319279212167	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	5	15	33.3333333333333	0.0277319279212167	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	PGR; EDNRB; SIX1; HES5; SIX4;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0277319279212167	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	IDO1; TDO2; IDO2;	GO:0019441~tryptophan catabolic process to kynurenine	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	WNT7A; NEFL; KEL;	GO:0031133~regulation of axon diameter	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	PEX5L; TCP11; RASD2;	GO:0043949~regulation of cAMP-mediated signaling	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	HMGB3; INHA; INHBA;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0279907264607087	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	SH2B2; PTPN2; ATP6V0D1; GRB2; ATP6V0E2; ATP6V0B; GRB14;	GO:0008286~insulin receptor signaling pathway	7	88	7.95454545454545	0.0281577397051409	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
up	CLDN14; CLDN8; CLDN17; CLDN18; CLDN2; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	6	21	28.5714285714286	0.0286160958286887	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	ITGAV; ALOX15; TGM2; AXL; MFGE8; TREM2;	GO:0043277~apoptotic cell clearance	6	21	28.5714285714286	0.0286160958286887	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	HP; CD36; HBB; HBA1;	GO:0010942~positive regulation of cell death	4	34	11.7647058823529	0.0292511566722538	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	TNF; PTK2B; FGD2; TLR6;	GO:0043507~positive regulation of JUN kinase activity	4	34	11.7647058823529	0.0292511566722538	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	CEBPB; CASP4; ATP2A3; TRIB3;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	4	34	11.7647058823529	0.0292511566722538	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	AQP9; PTK2B; TSC22D3;	GO:0006970~response to osmotic stress	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	RPA2; ZNF365; TERF2IP;	GO:0010569~regulation of double-strand break repair via homologous recombination	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	CES1; GPS2; EEPD1;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	MYO1F; MYO1G; MYO7B;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	MYO1G; CORO1A; EPHB1;	GO:0031589~cell-substrate adhesion	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	CST7; TNFRSF1B; ITGAX;	GO:0031643~positive regulation of myelination	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	FGR; RAC2; CSNK2B;	GO:0045859~regulation of protein kinase activity	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	TNFSF14; CD53; EHD1;	GO:1901741~positive regulation of myoblast fusion	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
down	FES; HCK; HCLS1;	GO:2000251~positive regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.0293513215531302	0.126801828563013	1	1	0.999436947074871	0.999436947074871	1
up	UNC5C; DCC; TUBB3; UNC5D;	GO:0038007~netrin-activated signaling pathway	4	10	40	0.0302774006557176	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	SERPINE1; THBS1; SERPINF2; HRG;	GO:0051918~negative regulation of fibrinolysis	4	10	40	0.0302774006557176	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	MFNG; ARRB1; PIN1; LRRK2; LFNG; TRIB3;	GO:0032092~positive regulation of protein binding	6	70	8.57142857142857	0.0303603167837977	0.129055962804208	1	1	0.999436947074871	0.999436947074871	1
up	ISLR; KNG1; PDGFB; APOA1; FN1; PDGFA; HRG; IGF1; APP; SERPINE1; CLEC3B; THBS1; SERPINF2; CD9; VEGFC; TGFB2; LGALS3BP; MMRN1; SCG3; RARRES2;	GO:0002576~platelet degranulation	20	124	16.1290322580645	0.0306724274265755	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	B3GAT3; FUT7; ST3GAL2; ST8SIA4; NAGPA; B3GALT6; ST3GAL6;	GO:0006486~protein glycosylation	7	90	7.77777777777778	0.0310736403720115	0.131803186561758	1	1	0.999436947074871	0.999436947074871	1
down	SDCBP; PIM2; MAP4K1; MAP2K3; STRADB; STK10; MAP3K3;	GO:0007346~regulation of mitotic cell cycle	7	90	7.77777777777778	0.0310736403720115	0.131803186561758	1	1	0.999436947074871	0.999436947074871	1
up	CEACAM5; CEACAM1; CDH13; FAT1; SDK2; FAT4; CADM3; CLSTN3; CADM1; CELSR3; TENM3; CDH22; PCDHGB4; PCDHA4; PCDHB5; PCDHGC4; CNTN4; MYOT; CDH19; L1CAM; CDH11; IGSF21; CDH26; CDH3; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	25	165	15.1515151515152	0.0313365248722433	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PTPN2; GRB2; EPGN; SH3KBP1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	4	35	11.4285714285714	0.0318203310789371	0.134824937287048	1	1	0.999436947074871	0.999436947074871	1
up	CYP1A1; CCNB1; CLDN18; FOXF1; FAT4; ALX4; MIXL1;	GO:0048565~digestive tract development	7	28	25	0.0321215999628406	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	CCL5; CCL23; XCL2;	GO:0048245~eosinophil chemotaxis	3	20	15	0.0329964917207377	0.139357900586402	1	1	0.999436947074871	0.999436947074871	1
down	CD160; PTPN2; PTPN6;	GO:0050860~negative regulation of T cell receptor signaling pathway	3	20	15	0.0329964917207377	0.139357900586402	1	1	0.999436947074871	0.999436947074871	1
down	RANGRF; FXYD6; FXYD5;	GO:2000649~regulation of sodium ion transmembrane transporter activity	3	20	15	0.0329964917207377	0.139357900586402	1	1	0.999436947074871	0.999436947074871	1
down	ADRB2; UBB; ARRB1; UBE2D1; LRRK2; NSMCE3;	GO:0031398~positive regulation of protein ubiquitination	6	72	8.33333333333333	0.0338946710834126	0.142997689592251	1	1	0.999436947074871	0.999436947074871	1
up	PRSS23; FSTL3; TSPAN15; KNG1; APOA1; FN1; IGF1; APP; APOA4; LAMB1; CTSG; MELTF; PGA3; PGA5; HRC; TNC; HSPG2; MFGE8; MSLN; TGFBI; TMEM132A; NOTUM; AMTN; HIST2H3A; SFTPA2; FAM20C; PCSK9; SCG3; EVA1A;	GO:0044267~cellular protein metabolic process	29	200	14.5	0.0341313008380578	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	ADRB2; GMPR; PCSK1N; UCP2;	GO:0009409~response to cold	4	36	11.1111111111111	0.034517629255154	0.145003545118873	1	1	0.999436947074871	0.999436947074871	1
down	PSMB8; PSMB10; PSMB3; PSMB9;	GO:0010498~proteasomal protein catabolic process	4	36	11.1111111111111	0.034517629255154	0.145003545118873	1	1	0.999436947074871	0.999436947074871	1
down	TPP1; ELANE; PPT1; P2RX7;	GO:0030163~protein catabolic process	4	36	11.1111111111111	0.034517629255154	0.145003545118873	1	1	0.999436947074871	0.999436947074871	1
down	FES; CELA1; RUNX3; PLEKHB1;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.034517629255154	0.145003545118873	1	1	0.999436947074871	0.999436947074871	1
down	TNF; SYK; BID; TCL1A; CLEC7A;	GO:0031334~positive regulation of protein-containing complex assembly	5	54	9.25925925925926	0.0356414877588739	0.147023324494329	1	1	0.999436947074871	0.999436947074871	1
down	AQP9; KCNE1; PTAFR; PIK3CG; KCNQ1;	GO:0071320~cellular response to cAMP	5	54	9.25925925925926	0.0356414877588739	0.147023324494329	1	1	0.999436947074871	0.999436947074871	1
down	AIF1; RHOG; RAC2;	GO:0016601~Rac protein signal transduction	3	21	14.2857142857143	0.0368654673068349	0.147762505046356	1	1	0.999436947074871	0.999436947074871	1
down	TYROBP; CD36; MARCO;	GO:0043277~apoptotic cell clearance	3	21	14.2857142857143	0.0368654673068349	0.147762505046356	1	1	0.999436947074871	0.999436947074871	1
down	TNF; FCER2; PTK2B;	GO:0051000~positive regulation of nitric-oxide synthase activity	3	21	14.2857142857143	0.0368654673068349	0.147762505046356	1	1	0.999436947074871	0.999436947074871	1
down	RAB29; RAB32; PACSIN1;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.0368654673068349	0.147762505046356	1	1	0.999436947074871	0.999436947074871	1
down	FRAT2; WNT1; FRAT1;	GO:1904886~beta-catenin destruction complex disassembly	3	21	14.2857142857143	0.0368654673068349	0.147762505046356	1	1	0.999436947074871	0.999436947074871	1
down	PDE6G; PDE6B; GNG2; PLCB2;	GO:0007223~Wnt signaling pathway, calcium modulating pathway	4	37	10.8108108108108	0.0373435519029748	0.149374207611899	1	1	0.999436947074871	0.999436947074871	1
down	GATA3; ID2; BTK; BFSP1;	GO:0048469~cell maturation	4	37	10.8108108108108	0.0373435519029748	0.149374207611899	1	1	0.999436947074871	0.999436947074871	1
up	FGF10; COL2A1; SOX9; SEMA3C;	GO:0060174~limb bud formation	4	11	36.3636363636364	0.0384514749492813	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	LAMA5; FGF7; TGM2; LAMA1;	GO:0060445~branching involved in salivary gland morphogenesis	4	11	36.3636363636364	0.0384514749492813	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	GJA4; GJC1; FSCN1; CDH19; CDH11; CDH3; CDH13; CDH26; CDH12;	GO:0007043~cell-cell junction assembly	9	43	20.9302325581395	0.0384593362690101	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	AIP; PRKCB; ZCCHC18; SCAND1; PKN1; DTX1; DAXX;	GO:1903508~positive regulation of nucleic acid-templated transcription	7	95	7.36842105263158	0.0392292610394104	0.156598430870012	1	1	0.999436947074871	0.999436947074871	1
up	FZD2; HEY2; VANGL2;	GO:0003150~muscular septum morphogenesis	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	F12; CLEC3B; MELTF;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	SERPINE1; THBS1; SERPINF2;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	NTRK1; NTF4; NTRK2;	GO:0042490~mechanoreceptor differentiation	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	INHA; INHBA; FOXL2;	GO:0046881~positive regulation of follicle-stimulating hormone secretion	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	UGT1A9; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	TCF21; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0392550581550236	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	APLNR; EXT1; WNT8B; MESP1; MIXL1; APLN;	GO:0007369~gastrulation	6	23	26.0869565217391	0.0394698897182086	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	FBXO7; GABARAP; WDR45; ATG3;	GO:0000422~autophagy of mitochondrion	4	38	10.5263157894737	0.0402983877063484	0.160540284155382	1	1	0.999436947074871	0.999436947074871	1
down	MYL4; TNNI3; TMOD1; TNNI2;	GO:0030049~muscle filament sliding	4	38	10.5263157894737	0.0402983877063484	0.160540284155382	1	1	0.999436947074871	0.999436947074871	1
up	FOXE1; TPO; SLC16A2; IYD; SLC5A5;	GO:0006590~thyroid hormone generation	5	17	29.4117647058824	0.0406399558775641	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	ABTB1; EEFSEC; EEF1A2;	GO:0006414~translational elongation	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	CA1; CA6; MTHFD2;	GO:0006730~one-carbon metabolic process	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	ALAS2; SLC25A38; SLC25A39;	GO:0006783~heme biosynthetic process	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	CDC34; PYHIN1; MNDA;	GO:0035458~cellular response to interferon-beta	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	NINJ1; NINJ2; CPQ;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	TNFSF14; BTG1; MEF2C;	GO:0045663~positive regulation of myoblast differentiation	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	HK3; PFKFB4; NAGK;	GO:0046835~carbohydrate phosphorylation	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	CACNA1E; P2RX4; P2RX7;	GO:0051899~membrane depolarization	3	22	13.6363636363636	0.0409557560725815	0.161684771965251	1	1	0.999436947074871	0.999436947074871	1
down	SLC1A7; P2RX1; SLC12A1; MLC1; SLC15A4; SLC24A4; FXYD5;	GO:0006811~ion transport	7	96	7.29166666666667	0.0410128566028186	0.16174779554893	1	1	0.999436947074871	0.999436947074871	1
down	TNF; SPI1; GATA3; CEBPD; CDKN1C; LOXL3; BASP1; ID2; HHEX; ARID5A; ZBTB16; ZNF174; BEND5; COMMD7; CIR1; NKAP; DEDD2; PBXIP1; EID2B; TRIB3; PFDN5; THAP7; KAT8; DAXX; TBX21;	GO:0045892~negative regulation of transcription, DNA-templated	25	530	4.71698113207547	0.041310561726286	0.162758645999756	1	1	0.999436947074871	0.999436947074871	1
down	PIK3CD; PIP4K2A; PIK3CG; BMX; PIK3R5; INPP5D;	GO:0006661~phosphatidylinositol biosynthetic process	6	76	7.89473684210526	0.0417341174625034	0.164262812675239	1	1	0.999436947074871	0.999436947074871	1
up	TNFSF11; FGF10; APOA1; IGF1; ITGAV; SOX9; CCL11;	GO:0070371~ERK1 and ERK2 cascade	7	30	23.3333333333333	0.042156648157408	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	CSF1R; PTAFR; PLCB2; PIK3CG; PIK3CD;	GO:0048015~phosphatidylinositol-mediated signaling	5	57	8.7719298245614	0.0427643097910433	0.16539555110145	1	1	0.999436947074871	0.999436947074871	1
up	LAMA5; PDGFA; INHBA; SOX18; SOX9; TGFB2; ALX4; VANGL2;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.0430373394144682	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	WNT7A; COL2A1; BMP2; SOX9; HMGA2; TGFBI; HES5; SIX2;	GO:0002062~chondrocyte differentiation	8	37	21.6216216216216	0.0430373394144682	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	STAT5A; MAP2K3; TMSB4X; P2RX4;	GO:0043536~positive regulation of blood vessel endothelial cell migration	4	39	10.2564102564103	0.0433822191841599	0.16539555110145	1	1	0.999436947074871	0.999436947074871	1
up	GRM6; GALR3; HTR3B; CPNE6; SYT1; GLRA1; SLC6A2; GJC1; NPTX2; SLC1A6; SLC18A2; GRIK2; GRIN2B; RAPSN; GPR176; GRM4; UNC13C; GAD1; NRXN1; PCDHB5; GABRA4; CACNB1; CACNB4; HTR4; GABRB2; CHRNA7; CHRM2; GABRA2; CHRND; NLGN2; HRH1; SLC12A4; GABRD; CHRNG;	GO:0007268~chemical synaptic transmission	34	249	13.6546184738956	0.0451575382339218	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	PRTN3; P2RX7; PSENEN;	GO:0006509~membrane protein ectodomain proteolysis	3	23	13.0434782608696	0.0452643477654853	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	TNF; CCR1; IL23R;	GO:0045672~positive regulation of osteoclast differentiation	3	23	13.0434782608696	0.0452643477654853	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	SNCA; RAB27A; UNC13D;	GO:0045921~positive regulation of exocytosis	3	23	13.0434782608696	0.0452643477654853	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	TNFRSF1B; CXCR4; ZNF365;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.0452643477654853	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	CXCR4; RNF157; CPNE5;	GO:1903861~positive regulation of dendrite extension	3	23	13.0434782608696	0.0452643477654853	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	IL18RAP; CD74; GNAI2; CSF1R; IRF2; GNG2; BRAT1; RASGRP4; MAP4K1;	GO:0008283~cell population proliferation	9	142	6.33802816901408	0.045776943553106	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	APBB1; NTNG2; SEMA4A; SLITRK4; ACTB; ISL2;	GO:0007409~axonogenesis	6	78	7.69230769230769	0.0460475637973683	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	PATL2; GZMB; RGS2; BTG2; PCIF1; PAIP2;	GO:0017148~negative regulation of translation	6	78	7.69230769230769	0.0460475637973683	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	POTEF; KRT1; ACTB; LYZ;	GO:0001895~retina homeostasis	4	40	10	0.046594928858027	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	MBP; GPX1; PSAP; KCNE1; KCNQ1; CDKN2D; GRAP; OTOF; MYO7B;	GO:0007605~sensory perception of sound	9	143	6.29370629370629	0.0473828427629885	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
up	CDH13; CDH22; PCDHGB4; PCDHB5; CDH26; CDH12; CDH11; CDH19; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	9	45	20	0.0474707679990781	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	LDHB; CHI3L1; SLC35A1; PGGHG; NPL; NAGPA; CHST2; B3GAT3;	GO:0005975~carbohydrate metabolic process	8	121	6.61157024793388	0.0476110115355578	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
up	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.0477606666704778	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	ITGB4; LAMB3; LAMC2; LAMA3;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.0477606666704778	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	APOA4; RGN; SLC45A3; APOA1;	GO:0045723~positive regulation of fatty acid biosynthetic process	4	12	33.3333333333333	0.0477606666704778	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
up	TERT; TBX3; EPCAM; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.0477606666704778	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	KIAA1324; ATG3; WDR45; GABARAP; ATG16L2;	GO:0000045~autophagosome assembly	5	59	8.47457627118644	0.047954661498692	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	FBP1; KCNQ1; CXCR4; MEF2C; RNF149;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.047954661498692	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
up	BMP2; AVPR2; SLC8A3; SCN5A; HES5;	GO:0021537~telencephalon development	5	18	27.7777777777778	0.0482512165825366	0.781098352789024	1	1	0.999999999669243	0.999999999669243	1
down	RPA2; CDC34; CDKN2D; CRLF3; POLE4; PIM2; GPR132;	GO:0000082~G1/S transition of mitotic cell cycle	7	100	7	0.0486694707782147	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	CD14; TBXA2R; GATA3; CD27; RGS2; RGS19; PTK2B;	GO:0045471~response to ethanol	7	100	7	0.0486694707782147	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	UBB; RPA2; POLD4;	GO:0006297~nucleotide-excision repair, DNA gap filling	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	HCLS1; PREX1; COTL1;	GO:0030833~regulation of actin filament polymerization	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	RPA2; POLD4; POLE4;	GO:0032201~telomere maintenance via semi-conservative replication	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	CD36; NPC2; EHD1;	GO:0034383~low-density lipoprotein particle clearance	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	TNF; EID2B; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	TLR4; LILRB3; INPP5D;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	GNAI2; SORL1; ADIPOR1;	GO:0046628~positive regulation of insulin receptor signaling pathway	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
down	PPBP; SLC5A9; SLC2A6;	GO:1904659~glucose transmembrane transport	3	24	12.5	0.0497877626455208	0.166439390499926	1	1	0.999436947074871	0.999436947074871	1
